HeartCore Enterprises, Inc. 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______, 20___, to _____, 20___. Commission File Number 001-41272 HeartCore Enterprises, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 87-0913420 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification Number) 1-2-33 , Higashigotanda , Shinagawa-ku Tokyo , Japan (Address of Principal Executive Offices) (Zip Code) (206) 385-0488 , ext. 100 (Registrant’s Telephone Number, Including Area Code) N/A (Former name, former address and former fiscal year, if changed since last report) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each Exchange on which Registered Common Stock HTCR The Nasdaq Capital Market Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☒ Emerging growth company ☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒ As of November 14, 2024, there were 20,933,797 shares of outstanding common stock, par value $ 0.0001 per share, of the registrant. HeartCore Enterprises, Inc. Contents Page PART I – FINANCIAL INFORMATION Item 1. Financial Statements F-1 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 3 Item 3. Quantitative and Qualitative Disclosures About Market Risk 14 Item 4. Controls and Procedures 14 PART II – OTHER INFORMATION Item 1. Legal Proceedings 15 Item 1A. Risk Factors 15 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 15 Item 3. Defaults Upon Senior Securities 15 Item 4. Mine Safety Disclosures 15 Item 5. Other Information 15 Item 6. Exhibits 15 Signatures 16 2 Item 1. Financial Statements. HEARTCORE ENTERPRISES, INC. CONSOLIDATED BALANCE SHEETS September 30, December 31, 2024 2023 (Unaudited) ASSETS Current assets: Cash and cash equivalents $ 1,232,117 $ 1,012,479 Accounts receivable 2,578,855 2,623,682 Investments in marketable securities 7,349,575 642,348 Investment in equity securities - 300,000 Prepaid expenses 769,183 536,865 Current portion of long-term note receivable 100,000 100,000 Due from related party 43,852 44,758 Other current assets 177,381 234,761 Total current assets 12,250,963 5,494,893 Non-current assets: Accounts receivable, non-current 766,972 - Property and equipment, net 663,447 763,730 Operating lease right-of-use assets 2,184,344 2,467,889 Intangible asset, net 4,037,500 4,515,625 Goodwill 3,276,441 3,276,441 Long-term investment in SAFE 350,000 - Long-term investment in equity securities 300,000 - Long-term investment in warrants 551,787 2,004,308 Long-term note receivable 200,000 200,000 Deferred tax assets 392,617 369,436 Security deposits 336,117 348,428 Long-term loan receivable from related party 146,354 182,946 Long-term loan receivable 146,354 182,946 Other non-current assets 15,812 71 Total non-current assets 13,221,391 14,128,874 Total assets $ 25,472,354 $ 19,623,767 LIABILITIES AND SHAREHOLDERS’ EQUITY Current liabilities: Accounts payable and accrued expenses $ 1,779,799 $ 1,757,038 Accounts payable and accrued expenses – related party 28,772 - Accounts payable and accrued expenses 28,772 - Accrued payroll and other employee costs 633,514 723,305 Due to related party 1,438 1,476 Short-term debt - 135,937 Current portion of long-term debts 462,121 371,783 Insurance premium financing 65,392 - Factoring liability 305,472 562,767 Operating lease liabilities, current 382,594 396,535 Finance lease liabilities, current 17,375 17,445 Income tax payables 170,453 162,689 Deferred revenue 1,927,582 2,166,175 Other current liabilities 756,766 216,405 Total current liabilities 6,531,278 6,511,555 Non-current liabilities: Long-term debts 1,382,048 1,770,352 Operating lease liabilities, non-current 1,859,948 2,135,160 Finance lease liabilities, non-current 52,005 66,779 Deferred tax liabilities 1,130,500 1,264,375 Other non-current liabilities 200,818 208,732 Total non-current liabilities 4,625,319 5,445,398 Total liabilities 11,156,597 11,956,953 Shareholders’ equity: Preferred shares ($ 0.0001 par value, 20,000,000 shares authorized, no shares issued and outstanding as of September 30, 2024 and December 31, 2023) - - Common shares ($ 0.0001 par value, 200,000,000 shares authorized; 20,864,144 and 20,842,690 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively) 2,085 2,083 Additional paid-in capital 18,997,059 19,594,801 Accumulated deficit ( 6,990,113 ) ( 14,763,469 ) Accumulated other comprehensive income 392,397 331,881 Total HeartCore Enterprises, Inc. shareholders’ equity 12,401,428 5,165,296 Non-controlling interests 1,914,329 2,501,518 Total shareholders’ equity 14,315,757 7,666,814 Total liabilities and shareholders’ equity $ 25,472,354 $ 19,623,767 The accompanying notes are an integral part of these unaudited consolidated financial statements. F- 1 HEARTCORE ENTERPRISES, INC. UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) 2024 2023 2024 2023 For the Three Months Ended September 30, For the Nine Months Ended September 30, 2024 2023 2024 2023 Revenues $ 17,850,411 $ 4,688,908 $ 26,963,531 $ 18,518,431 Cost of revenues 3,433,024 3,860,241 9,708,074 10,548,245 Gross profit 14,417,387 828,667 17,255,457 7,970,186 Operating expenses: Selling expenses 243,110 274,043 642,225 1,330,747 General and administrative expenses 1,966,717 2,172,298 6,395,429 7,305,392 Research and development expenses 107,529 170,071 307,931 289,303 Total operating expenses 2,317,356 2,616,412 7,345,585 8,925,442 Income (loss) from operations 12,100,031 ( 1,787,745 ) 9,909,872 ( 955,256 ) Other income (expenses): Changes in fair value of investments in marketable securities 122,272 ( 271,740 ) ( 308,059 ) ( 500,762 ) Changes in fair value of investment in warrants 2,869,407 ( 460,672 ) 1,631,700 ( 294,565 ) Loss on sale of warrants ( 3,970,628 ) - ( 3,970,628 ) - Interest income 10,933 14,363 15,557 64,633 Interest expenses ( 31,393 ) ( 42,619 ) ( 105,094 ) ( 125,073 ) Other income 24,040 52,640 158,914 176,641 Other expenses ( 82,457 ) ( 25,947 ) ( 131,507 ) ( 62,701 ) Total other expenses ( 1,057,826 ) ( 733,975 ) ( 2,709,117 ) ( 741,827 ) Income (loss) before income tax provision 11,042,205 ( 2,521,720 ) 7,200,755 ( 1,697,083 ) Income tax expense 225,275 19,413 72,945 58,859 Net income (loss) 10,816,930 ( 2,541,133 ) 7,127,810 ( 1,755,942 ) Less: net loss attributable to non-controlling interests ( 240,876 ) ( 233,913 ) ( 645,546 ) ( 419,211 ) Net income (loss) attributable to HeartCore Enterprises, Inc. $ 11,057,806 $ ( 2,307,220 ) $ 7,773,356 $ ( 1,336,731 ) Other comprehensive income (loss): Foreign currency translation adjustment 65,503 ( 90,743 ) 51,678 ( 85,244 ) Total comprehensive income (loss) 10,882,433 ( 2,631,876 ) 7,179,488 ( 1,841,186 ) Less: comprehensive loss attributable to non-controlling interests ( 241,913 ) ( 235,094 ) ( 654,384 ) ( 422,352 ) Comprehensive income (loss) attributable to HeartCore Enterprises, Inc. $ 11,124,346 $ ( 2,396,782 ) $ 7,833,872 $ ( 1,418,834 ) Net income (loss) per common share attributable to HeartCore Enterprises, Inc. Basic $ 0.53 $ ( 0.11 ) $ 0.37 $ ( 0.07 ) Diluted $ 0.53 $ ( 0.11 ) $ 0.37 $ ( 0.07 ) Weighted average common shares outstanding Basic 20,864,144 20,842,690 20,861,012 20,257,020 Diluted 20,864,144 20,842,690 20,861,012 20,257,020 The accompanying notes are an integral part of these unaudited consolidated financial statements. F- 2 HEARTCORE ENTERPRISES, INC. UNAUDITED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023 Number of Shares Amount Paid-in Capital Accumulated Deficit Comprehensive Income Shareholders’ Equity Non-controlling Interests Shareholders’ Equity Common Shares Additional Accumulated Other Total HeartCore Enterprises, Inc. Total Number of Shares Amount Paid-in Capital Accumulated Deficit Comprehensive Income Shareholders’ Equity Non-controlling Interests Shareholders’ Equity Balance, December 31, 2023 20,842,690 $ 2,083 $ 19,594,801 $ ( 14,763,469 ) $ 331,881 $ 5,165,296 $ 2,501,518 $ 7,666,814 Net loss - - - ( 1,333,350 ) - ( 1,333,350 ) ( 144,652 ) ( 1,478,002 ) Foreign currency translation adjustment - - - - 15,206 15,206 ( 4,911 ) 10,295 Capital contribution from non-controlling shareholder - - - - - - 67,195 67,195 Stock-based compensation 21,454 2 91,710 - - 91,712 - 91,712 Balance, March 31, 2024 20,864,144 2,085 19,686,511 ( 16,096,819 ) 347,087 3,938,864 2,419,150 6,358,014 Net loss - - - ( 1,951,100 ) - ( 1,951,100 ) ( 260,018 ) ( 2,211,118 ) Foreign currency translation adjustment - - - - ( 21,230 ) ( 21,230 ) ( 2,890 ) ( 24,120 ) Distribution of dividends - - ( 417,283 ) - - ( 417,283 ) - ( 417,283 ) Stock-based compensation - - 56,042 - - 56,042 - 56,042 Balance, June 30, 2024 20,864,144 2,085 19,325,270 ( 18,047,919 ) 325,857 1,605,293 2,156,242 3,761,535 Net income (loss) - - - 11,057,806 - 11,057,806 ( 240,876 ) 10,816,930 Foreign currency translation adjustment - - - - 66,540 66,540 ( 1,037 ) 65,503 Distribution of dividends - - ( 417,283 ) - - ( 417,283 ) - ( 417,283 ) Stock-based compensation - - 89,072 - - 89,072 - 89,072 Balance, September 30, 2024 20,864,144 $ 2,085 $ 18,997,059 $ ( 6,990,113 ) $ 392,397 $ 12,401,428 $ 1,914,329 $ 14,315,757 Common Shares Additional Accumulated Other Total HeartCore Enterprises, Inc. Total Number of Shares Amount Paid-in Capital Accumulated Deficit Comprehensive Income Shareholders’ Equity Non-controlling Interest Shareholders’ Equity Balance, December 31, 2022 17,649,886 $ 1,764 $ 15,014,607 $ ( 10,573,579 ) $ 364,837 $ 4,807,629 $ - $ 4,807,629 Net income (loss) - - - 1,882,289 - 1,882,289 ( 74,252 ) 1,808,037 Foreign currency translation adjustment - - - - ( 22,744 ) ( 22,744 ) ( 2,290 ) ( 25,034 ) Issuance of common shares for acquisition of subsidiary 2,500,000 250 3,149,750 - - 3,150,000 - 3,150,000 Non-controlling interest arising from acquisition of subsidiary - - - - - - 3,190,000 3,190,000 Stock-based compensation 692,804 69 915,159 - - 915,228 - 915,228 Balance, March 31, 2023 20,842,690 2,083 19,079,516 ( 8,691,290 ) 342,093 10,732,402 3,113,458 13,845,860 Net loss - - - ( 911,800 ) - ( 911,800 ) ( 111,046 ) ( 1,022,846 ) Foreign currency translation adjustment - - - - 30,203 30,203 330 30,533 Stock-based compensation - - 179,165 - - 179,165 - 179,165 Balance, June 30, 2023 20,842,690 2,083 19,258,681 ( 9,603,090 ) 372,296 10,029,970 3,002,742 13,032,712 Balance 20,842,690 2,083 19,258,681 ( 9,603,090 ) 372,296 10,029,970 3,002,742 13,032,712 Net loss - - - ( 2,307,220 ) - ( 2,307,220 ) ( 233,913 ) ( 2,541,133 ) Net income (loss) - - - ( 2,307,220 ) - ( 2,307,220 ) ( 233,913 ) ( 2,541,133 ) Foreign currency translation adjustment - - - - ( 89,562 ) ( 89,562 ) ( 1,181 ) ( 90,743 ) Stock-based compensation - - 173,306 - - 173,306 - 173,306 Balance, September 30, 2023 20,842,690 $ 2,083 $ 19,431,987 $ ( 11,910,310 ) $ 282,734 $ 7,806,494 $ 2,767,648 $ 10,574,142 Balance 20,842,690 $ 2,083 $ 19,431,987 $ ( 11,910,310 ) $ 282,734 $ 7,806,494 $ 2,767,648 $ 10,574,142 The accompanying notes are an integral part of these unaudited consolidated financial statements. F- 3 HEARTCORE ENTERPRISES, INC. UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS 2024 2023 For the Nine Months Ended September 30, 2024 2023 Cash flows from operating activities: Net income (loss) $ 7,127,810 $ ( 1,755,942 ) Adjustments to reconcile net income (loss) to net cash flows used in operating activities: Depreciation and amortization expenses 561,659 495,200 Loss (gain) on disposal of property and equipment 1,894 ( 4,737 ) Amortization of debt issuance costs 3,791 2,257 Non-cash lease expense 272,208 254,876 Loss (gain) on termination of lease ( 469 ) 76 Deferred income taxes ( 163,199 ) ( 109,690 ) Stock-based compensation 236,826 1,267,699 Marketable securities received as noncash consideration ( 572,010 ) - Warrants received as noncash consideration ( 12,969,683 ) ( 4,009,335 ) Changes in fair value of investments in marketable securities 308,059 500,762 Changes in fair value of investment in warrants ( 1,631,700 ) 294,565 Loss on sale of warrants 3,970,628 - Changes in assets and liabilities: Accounts receivable ( 685,531 ) ( 322,583 ) Prepaid expenses ( 72,315 ) 187,269 Other assets 40,761 ( 23,982 ) Accounts payable and accrued expenses 34,752 597,247 Accounts payable and accrued expenses – related party 28,315 - Accounts payable and accrued expenses 28,315 - Accrued payroll and other employee costs ( 68,323 ) 7,471 Due to related party ( 7 ) 7,562 Operating lease liabilities ( 275,850 ) ( 231,499 ) Income tax payables 17,971 101,058 Deferred revenue ( 205,109 ) 200,256 Other liabilities 540,008 83,809 Net cash flows used in operating activities ( 3,499,514 ) ( 2,457,661 ) Cash flows from investing activities: Purchases of property and equipment ( 4,134 ) ( 516,658 ) Proceeds from disposal of property and equipment - 24,935 Advance on note receivable - ( 600,000 ) Purchase of long-term investment in SAFE ( 350,000 ) - Net proceeds from sale of warrants 5,640,000 - Repayment of loan provided to related party 31,457 34,823 Payment for acquisition of subsidiary, net of cash acquired - ( 724,910 ) Net cash flows provided by (used in) investing activities 5,317,323 ( 1,781,810 ) Cash flows from financing activities: Payments for finance leases ( 12,568 ) ( 16,537 ) Proceeds from short-term and long-term debts 68,138 219,427 Repayment of short-term and long-term debts ( 453,048 ) ( 584,779 ) Repayment of insurance premium financing ( 107,297 ) ( 266,756 ) Net proceeds from factoring arrangement - 217,250 Net repayment of factoring arrangement ( 257,295 ) - Payments for debt issuance costs - ( 656 ) Distribution of dividends ( 834,566 ) - Capital contribution from non-controlling shareholder 67,195 - Net cash flows used in financing activities ( 1,529,441 ) ( 432,051 ) Effect of exchange rate changes ( 68,730 ) ( 306,239 ) Net change in cash and cash equivalents 219,638 ( 4,977,761 ) Cash and cash equivalents – beginning of the period 1,012,479 7,177,326 Cash and cash equivalents – end of the period $ 1,232,117 $ 2,199,565 Supplemental cash flow disclosures: Interest paid $ 104,880 $ 59,290 Income taxes paid $ 201,035 $ 91,657 Non-cash investing and financing transactions: Finance lease right-of-use assets obtained in exchange for finance lease liabilities $ - $ 93,117 Operating lease right-of-use assets obtained in exchange for operating lease liabilities $ 125,735 $ 317,040 Remeasurement of operating lease liabilities and right-of-use assets due to lease modification $ - $ 12,579 Liabilities assumed in connection with purchase of property and equipment $ - $ 9,602 Insurance premium financing $ 172,689 $ 389,035 Common shares issued for acquisition of subsidiary $ - $ 3,150,000 Warrants converted to marketable securities $ 6,443,276 $ 1,257,868 The accompanying notes are an integral part of these unaudited consolidated financial statements. F- 4 HEARTCORE ENTERPRISES, INC. NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS HeartCore Enterprises, Inc. (“HeartCore USA” or the “Company”), a holding company, was incorporated under the laws of the State of Delaware on May 18, 2021. On July 16, 2021, the Company executed a share exchange agreement with certain shareholders of HeartCore Co., Ltd. (“HeartCore Japan”), a company that was incorporated in Japan on June 12, 2009. Pursuant to the terms of the share exchange agreement, the Company issued 15,999,994 shares of its common shares to the shareholders of HeartCore Japan in exchange for 10,706 shares out of 10,984 shares of common shares issued by HeartCore Japan, representing approximately 97.5 % of HeartCore Japan’s outstanding common shares. On February 24, 2022, the Company purchased the remaining 278 shares of common shares of HeartCore Japan. As a result, HeartCore Japan became a wholly-owned operating subsidiary of the Company. The share exchange on July 16, 2021 has been accounted for as a recapitalization between entities under common control since the same controlling shareholders controlled these two entities before and after the transaction. The consolidation of the Company and its subsidiary has been accounted for at historical cost and prepared on the basis as if the transaction had become effective as of the beginning of the earliest period presented in the accompanying unaudited consolidated financial statements. The Company, via its wholly-owned operating subsidiary, HeartCore Japan, is mainly engaged in the business of developing and sales of comprehensive software. Beginning from early 2022, HeartCore USA is engaged in the business of providing consulting services to Japanese companies with intention to go public in the United States capital market. On September 6, 2022, HeartCore USA entered into a share exchange and purchase agreement (“Sigmaways Agreement”) to acquire 51 % of the outstanding shares of Sigmaways, Inc. (“Sigmaways”), a company incorporated under the laws of the State of California in April 2006, and its wholly-owned subsidiaries, Sigmaways B.V. and Sigmaways Technologies Ltd. (“Sigmaways Technologies”). Sigmaways B.V. was incorporated in Netherlands in November 2019. Sigmaways Technologies was incorporated in Canada in August 2020. Sigmaways and its wholly-owned subsidiaries are primarily engaged in the business of developing and sales of software in the United States. The acquisition was closed on February 1, 2023. In January 2023, HeartCore USA incorporated a wholly-owned subsidiary, HeartCore Financial, Inc. (“HeartCore Financial”), under the laws of the State of Delaware. HeartCore Financial is engaged in the business of providing financial consulting services. In February 2023, HeartCore USA incorporated a wholly-owned subsidiary, HeartCore Capital Advisors, Inc. (“HeartCore Capital Advisors”), in Japan. HeartCore Capital Advisors is engaged in the business of providing financial consulting services to Japanese companies. In November 2023, HeartCore Japan established a 51 % owned subsidiary in Vietnam, HeartCore Luvina Vietnam Company Limited (“HeartCore Luvina”), which is engaged in the business of providing software development and other services. HeartCore Luvina started its operations from February 2024. On November 17, 2023, HeartCore Japan and HeartCore Capital Advisors entered into a merger agreement to merge the two entities into one with HeartCore Japan being the surviving entity. On January 1, 2024, the merger was completed and HeartCore Capital Advisors transferred all of its assets and liabilities to HeartCore Japan. The merger has been accounted for as a recapitalization between entities under common control since the same controlling shareholders controlled the two entities before and after the transaction. In April 2024, HeartCore Financial incorporated a branch office, HeartCore Financial, Inc. – Japan Branch Office (“HeartCore Financial – Japan”), in Japan. HeartCore Financial – Japan is engaged in the business of providing financial consulting services. HeartCore USA, HeartCore Japan, Sigmaways, Sigmaways B.V., Sigmaways Technologies, HeartCore Financial, HeartCore Capital Advisors, HeartCore Luvina and HeartCore Financial – Japan are hereafter referred to as the Company. F- 5 NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation and Principles of Consolidation The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The unaudited consolidated financial statements include the accounts of the Company and its subsidiaries. All significant intercompany accounts and transactions have been eliminated. These unaudited interim consolidated financial statements do not include all of the information and disclosure required by the U.S. GAAP for complete financial statements. Interim results are not necessarily indicative of results for a full year. In the opinion of management, all adjustments consisting of normal recurring nature considered necessary for a fair presentation of the financial position and the results of operations and cash flows for the interim periods have been included. The unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes for the year ended December 31, 2023. Use of Estimates In preparing the unaudited consolidated financial statements in conformity U.S. GAAP, the management is required to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are based on information available as of the date of the unaudited consolidated financial statements. Significant estimates required to be made by management include, but are not limited to, the allowance for credit losses, useful lives of property and equipment and intangible asset, the impairment of long-lived assets and goodwill, valuation of stock-based compensation, valuation allowance of deferred tax assets, implicit interest rate of operating and finance leases, valuation of asset retirement obligations, valuation of investment in warrants, revenue recognition and purchase price allocation with respect to business combination. Actual results could differ from those estimates. Asset Retirement Obligations Pursuant to the lease agreements for the office space, the Company is responsible to restore these spaces back to its original statute at the time of leaving. The Company recognizes an obligation related to these restorations as asset retirement obligation included in other non-current liabilities in the consolidated balance sheets, in accordance with the Financial Accounting Standards Board’s (the “FASB”) Accounting Standards Codification (“ASC”) Topic 410, “Asset Retirement Obligation Accounting”. The Company capitalizes the associated asset retirement cost by increasing the carrying amount of the related property and equipment. The following table presents changes in asset retirement obligations: SCHEDULE OF CHANGES IN ASSET RETIREMENT OBLIGATIONS September 30, December 31, 2024 2023 Beginning balance $ 208,732 $ 138,018 Liabilities incurred - 83,821 Accretion expense 257 428 Liabilities settled ( 3,779 ) - Foreign currency translation adjustment ( 4,392 ) ( 13,535 ) Ending balance $ 200,818 $ 208,732 Software Development Costs Software development costs are expensed as incurred until the point the Company establishes technological feasibility. Technological feasibility is established upon completion of a detailed program design or the completion of a working model. Costs incurred by the Company between establishment of technological feasibility and the point at which the product is ready for general release are capitalized and amortized over the economic life of the related products. The Company’s software development costs incurred subsequent to achieving technological feasibility have not been significant and all software development costs have been expensed as incurred. In the nine months ended September 30, 2024 and 2023, software development costs expensed as incurred amounted to $ 307,931 and $ 289,303 , respectively. These software development costs were included in the research and development expenses. Investment in Warrants Investment in warrants represents stock warrants of its consulting service customers. The warrants are measured at fair value and any changes in fair value are recognized in other income (expenses). Investment in warrants is classified as long-term if the warrants are exercisable over one year after the date of receipt. F- 6 Investments in Marketable Securities Investments in marketable securities represent equity securities registered for public sale with readily determinable fair value. The marketable securities were obtained through stocks of its customers as noncash consideration from consulting services and through exercise of stock warrants of its consulting service customers and measured at fair value with changes in fair value recognized in other income (expenses). Investment in Equity Securities Investment in equity securities represents investment in a privately held entity that does not have a readily determinable fair value or report net asset value. Investment in equity securities is accounted for using a measurement alternative, under which this investment is measured at cost, adjusted for observable price changes and impairments, with changes recognized in other income (expenses). Investment in equity securities is classified as long-term if the Company anticipates to dispose of the investment over one year after the date of receipt based on information available as of the date the unaudited consolidated financial statements are issued. The Company did not recognize any impairment loss on investment in equity securities for the nine months ended September 30, 2024. Investment in SAFE Investment in SAFE represents investment in a privately held entity that does not have a readily determinable fair value or report net asset value through a simple agreement for future equity (“SAFE”). Investment in SAFE is accounted for using a measurement alternative, under which this investment is measured at cost, adjusted for observable price changes and impairments, with changes recognized in other income (expenses). Investment in SAFE is classified as long-term if the Company anticipates the equity financing or dissolution or liquidity event prescribed in the SAFE to take place over one year after the date of receipt based on information available as of the date the unaudited consolidated financial statements are issued. The Company did not recognize any impairment loss on investment in SAFE for the nine months ended September 30, 2024. Intangible Asset, Net Intangible asset represents the customer relationship acquired from business acquisition of Sigmaways and its subsidiaries. The acquired intangible asset is recognized and measured at fair value at the time of acquisition and is amortized on a straight-line basis over the estimated economic useful life of the respective asset. The estimated useful life of the customer relationship is 8 years . Impairment of Long-Lived Assets Other Than Goodwill Long-lived assets with finite lives, primarily property and equipment, operating lease right-of-use assets and intangible asset, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If the estimated cash flows from the use of the asset and its eventual disposition are below the asset’s carrying value, then the asset is deemed to be impaired and written down to its fair value. There were no impairments of these assets during the nine months ended September 30, 2024 and 2023. Goodwill Goodwill represents the excess of the purchase price over the fair value of the net identifiable assets acquired in a business combination. In accordance with ASC Topic 350, “Intangibles – Goodwill and Others”, goodwill is subject to at least an annual assessment for impairment or more frequently if events or changes in circumstances indicate that an impairment may exist, applying a fair-value based test. Fair value is generally determined using a discounted cash flow analysis. Foreign Currency Translation The functional currency of HeartCore Japan, HeartCore Capital Advisors and HeartCore Financial – Japan is the Japanese Yen (“JPY”). The functional currency of HeartCore USA, HeartCore Financial and Sigmaways is the United States Dollar (“US$”). The functional currency of Sigmaways B.V. is the Euro (“EUR”). The functional currency of Sigmaways Technologies is the Canada Dollar (“CAD”). The functional currency of HeartCore Luvina is the Vietnam Dong (“VND”). Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the unaudited consolidated statements of operations and comprehensive income (loss). The reporting currency of the Company is the US$, and the accompanying unaudited consolidated financial statements have been expressed in US$. In accordance with ASC Topic 830-30, “Translation of Financial Statements”, assets and liabilities of the Company whose functional currency is not US$ are translated into US$, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from the translation of financial statements are recorded as a separate component of accumulated other comprehensive income within the unaudited consolidated statements of changes in shareholders’ equity. F- 7 Revenue Recognition The Company recognizes revenues under ASC Topic 606, “Revenue from Contracts with Customers”. To determine revenue recognition for contracts with customers, the Company performs the following five steps: (i) identify the contract(s) with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance obligation. Revenues amount represents the invoiced value, net of a value-added tax (“Consumption Tax”) and applicable local government levies. The Consumption Tax on sales are calculated at 10% of gross sales in Japan and Vietnam, 5% of gross sales in Canada, 21% of gross sales in Netherlands and nil of gross sales in the United States. The Company currently generates its revenue from the following main sources: Revenues from On-premise Software Licenses for on-premise software provide the customers with a right to use the software as it exists when made available to the customers. The Company provides on-premise software in the form of both perpetual licenses and term-based licenses which grant the customers with the right for a specified term. Revenues from on-premise licenses are recognized upfront at the point in time when the software is made available to the customers. Licenses for on-premise software are typically sold to the customers with maintenance and support services in a bundle. Revenues under the bundled arrangements are allocated based on the relative standalone selling prices (“SSP”) of on-premise software and maintenance and support service. The SSP for maintenance and support services is estimated based upon observable transactions when those services are sold on a standalone basis. The SSP of on-premise software is typically estimated using the residual approach as the Company is unable to establish the SSP for on-premise licenses based on observable prices given the same products are sold for a broad range of amounts (that is, the selling price is highly variable) and a representative SSP is not discernible from past transactions or other observable evidence. Revenues from Maintenance and Support Services Maintenance and support services provided with software licenses consist of trouble shooting, technical support and the right to receive unspecified software updates when and if available during the subscription. Revenues from maintenance and support services are recognized over time as such services are performed. Revenues for consumption-based services are generally recognized as the services are performed and accepted by the customers. Revenues from Software as a Service (“SaaS”) The Company’s software is available for use as hosted application arrangements under subscription fee agreements without licensing the rights of the software to the customers. Subscription fees from these applications are recognized over time on a ratable basis over the customer agreement term beginning on the date the Company’s solution is made available to the customers. The subscription contracts are generally one year or less in length. Revenues from Software Development and Other Miscellaneous Services The Company provides customers with software development and support services pursuant to their specific requirements, which primarily compose of consulting, integration, training, custom application, and workflow development. The Company also provides other miscellaneous services, such as 3D Space photography. The Company generally recognizes revenues at a point in time when control is transferred to the customers and the Company is entitled to the payment, which is when the promised services are delivered and accepted by the customers. F- 8 Revenues from Customized Software Development and Services The Company’s customized software development and services revenues primarily include revenues from providing software development solutions and other support services to its customers. The contract pricing is at stated billing rates per hour. These contracts are generally short-term in nature and not longer than one year in duration. For services provided under the contracts that result in the transfer of control over time, the underlying deliverable in the contracts is owned and controlled by the customers and does not create an asset with an alternative use to the Company. The Company recognizes revenues on rate per hour contracts based on the amount billable to the customers, as the Company has the right to invoice the customers in an amount that directly corresponds with the value to the customers of the Company’s performance to date. Revenues from Consulting Services The Company provides public listing related consulting services to customers pursuant to the specific requirements prescribed in the contracts, which primarily include communicating with intermediary parties, preparing required documents related to the initial public offering and supporting the listing process. The consulting service contracts normally include both cash and noncash considerations. Cash consideration is paid in installment payments and is recognized in revenues over the period of the contract by reference to progress toward complete satisfaction of that performance obligation. Noncash consideration is in the form of warrants of the customers and is measured at fair value at contract inception. Noncash consideration that is variable for reasons other than only the form of the consideration is included in the transaction price, but is subject to the constraint on variable consideration. The Company assesses the estimated amount of the variable noncash consideration at contract inception and subsequently, to determine when and to what extent it is probable that a significant reversal in the amount of cumulative revenues recognized will not occur once the uncertainty associated with the variable consideration is subsequently resolved. Only when the significant revenues reversal is concluded probable of not occurring can variable consideration be included in revenues. Based on evaluation of likelihood and magnitude of a reversal in applying the constraint, the variable noncash consideration is recognized in revenues until the underlying uncertainties have been resolved. The Company records reduction to revenues for estimated customer returns and allowances. The Company bases its estimates on historical rates of customer returns and allowances as well as the specific identification of outstanding returns. The actual amount of customer returns and allowances, which is inherently uncertain, may differ from the Company’s estimates. If the Company determines that actual or expected returns or allowances are significantly higher or lower than the reserves it established, it would record a reduction or increase, as appropriate, to revenues in the period in which it makes such a determination. Reserves for customer refunds are included within other current liabilities on the consolidated balance sheets. At a minimum, the Company reviews and refines these estimates on a quarterly basis. The timing of revenue recognition may differ from the timing of invoicing to the customers. The Company has determined that its contracts do not include a significant financing component. The Company records a contract asset, which is included in accounts receivable, current or non-current, in the consolidated balance sheets, when revenues are recognized prior to invoicing. The Company factors certain accounts receivable upon or after the performance obligation is being met. The Company records deferred revenue in the consolidated balance sheets when revenues are recognized subsequent to cash collection for an invoice. Deferred revenue is reported net of related uncollected deferred revenue in the consolidated balance sheets. The amount of revenues recognized during the nine months ended September 30, 2024 and 2023 that were included in the opening deferred revenue balance was approximately $ 1.8 million and $ 1.5 million, respectively. F- 9 Disaggregation of Revenues The Company disaggregates its revenues from contracts by product/service types, as the Company believes it best depicts how the nature, amount, timing and uncertainty of the revenues and cash flows are affected by economic factors. The Company’s disaggregation of revenues by revenue stream for the three and nine months ended September 30, 2024 and 2023 is as following: SCHEDULE OF DISAGGREGATION OF REVENUES 2024 2023 2024 2023 For the Three Months Ended September 30, For the Nine Months Ended September 30, 2024 2023 2024 2023 Revenues from on-premise software $ 681,065 $ 396,647 $ 2,335,225 $ 1,457,836 Revenues from maintenance and support services 557,432 650,603 1,734,480 2,226,802 Revenues from software as a service (“SaaS”) 55,092 148,857 347,040 497,430 Revenues from software development and other miscellaneous services 428,968 474,859 1,392,987 1,561,655 Revenues from customized software development and services 2,243,504 2,405,907 6,543,156 6,332,479 Revenues from consulting services 13,884,350 612,035 14,610,643 6,442,229 Total revenues $ 17,850,411 $ 4,688,908 $ 26,963,531 $ 18,518,431 The Company’s disaggregation of revenues by product/service is as following: 2024 2023 2024 2023 For the Three Months Ended September 30, For the Nine Months Ended September 30, 2024 2023 2024 2023 Revenues from customer experience management platform $ 1,549,000 $ 1,403,932 $ 5,029,173 $ 4,696,241 Revenues from process mining 13,720 99,618 188,182 390,374 Revenues from robotic process automation 48,171 58,051 206,735 271,520 Revenues from task mining 83,667 74,958 236,887 277,725 Revenues from customized software development and services 2,243,504 2,405,907 6,543,156 6,332,479 Revenues from consulting services 13,884,350 612,035 14,610,643 6,442,229 Revenues from others 27,999 34,407 148,755 107,863 Total revenues $ 17,850,411 $ 4,688,908 $ 26,963,531 $ 18,518,431 As of September 30, 2024 and 2023, and for the periods then ended, the majority of the long-lived assets (excluding intangible asset) and revenues generated were attributed to the Company’s operation in Japan. Concentration of Credit Risk Financial instruments that potentially subject the Company to credit risk consist primarily of accounts receivable, note receivable and other receivable. The Company usually does not require collateral or other security to support these receivables. The Company conducts periodic reviews of the financial condition and payment practices of its customers to minimize collection risk on accounts receivable. For the nine months ended September 30, 2024, customer A represents 49.3 % of the Company’s total revenues. For the nine months ended September 30, 2023, customer B and C represent 14.2 % and 13.6 %, respectively, of the Company’s total revenues. For the nine months ended September 30, 2024, no vendor accounts for more than 10% of the Company’s total purchases. For the nine months ended September 30, 2023, vendor A, B, C and D represent 26.4 %, 26.2 %, 22.1 % and 15.9 %, respectively, of the Company’s total purchases. F- 10 Stock-based Compensation The Company accounts for stock-based compensation awards in accordance with ASC Topic 718, “Compensation – Stock Compensation”. The cost of services received from employees and non-employees in exchange for awards of equity instruments is recognized in the unaudited consolidated statements of operations and comprehensive income (loss) based on the estimated fair value of those awards on the grant date and amortized on a straight-line basis over the requisite service period or vesting period. The Company records forfeitures as they occur. Business Combinations The Company accounts its business combinations using the acquisition method of accounting in accordance with ASC Topic 805. The purchase price of the acquisition is allocated to the tangible assets, liabilities, identifiable intangible asset acquired and non-controlling interests, if any, based on their estimated fair values as of the acquisition date. The excess of the purchase price over those fair values is recorded as goodwill. Acquisition-related expenses are expensed as incurred. Consideration transferred in a business combination is measured at the fair value as of the date of acquisition. Where the consideration in an acquisition includes contingent consideration, and the payment of which depends on the achievement of certain specified conditions post-acquisition, the contingent consideration is recognized and measured at its fair value at the acquisition date and is recorded as a liability. It is subsequently carried at fair value with changes in fair value reflected in earnings. In a business combination achieved in stages, the Company remeasures the previously held equity interest in the acquiree immediately before obtaining control at its acquisition-date fair value and the remeasurement gain or loss, if any, is recognized in the unaudited consolidated statements of operations and comprehensive income (loss). Fair value is determined based upon the guidance of ASC Topic 820, “Fair Value Measurements and Disclosures”, and generally are determined using Level 2 inputs and Level 3 inputs. The determination of fair value involves the use of significant judgments and estimates. The Company utilizes the assistance of a third-party valuation appraiser to determine the fair value as of the date of acquisition. Fair Value Measurements The Company performs fair value measurements in accordance with ASC Topic 820. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. An asset’s or a liability’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC Topic 820 establishes three levels of inputs that may be used to measure fair value: ● Level 1: quoted prices in active markets for identical assets or liabilities; ● Level 2: inputs other than Level 1 that are observable, either directly or indirectly; or ● Level 3: unobservable inputs that are supported by little or no market activity and that are significant to the fair values of the assets or liabilities. As of September 30, 2024 and December 31, 2023, the carrying values of current assets, except for investments in marketable securities, and current liabilities approximated their fair values reported in the consolidated balance sheets due to the short-term maturities of these instruments. F- 11 Assets measured at fair value on a recurring basis as of September 30, 2024 and December 31, 2023 are summarized below (also see NOTE 6): SCHEDULE OF ASSETS MEASURED AT FAIR VALUE ON A RECURRING BASIS Fair Value Measurements as of September 30, 2024 Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Unobservable Inputs (Level 3) Fair Value at September 30, 2024 Investments in marketable securities 7,349,575 - - 7,349,575 Long-term investment in warrants - - 551,787 551,787 Fair Value Measurements as of December 31, 2023 Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Unobservable Inputs (Level 3) Fair Value at December 31, 2023 Investments in marketable securities 642,348 - - 642,348 Long-term investment in warrants - - 2,004,308 2,004,308 Recent Accounting Pronouncements In November 2023, the FASB issued Accounting Standards Update (“ASU”) No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses. ASU No. 2023-07 is effective for public companies for annual reporting periods beginning after December 15, 2023, on a retrospective basis. Early adoption is permitted. The Company is currently evaluating the impact of this ASU on its unaudited consolidated financial statements and related disclosures. In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvement to Income Tax Disclosures, to enhance the transparency and decision usefulness of income tax disclosures, primarily related to the rate reconciliation and income taxes paid information. ASU No. 2023-09 is effective for public companies for annual reporting periods beginning after December 15, 2024, on a prospective basis. For all other entities, it is effective for annual reporting periods beginning after December 15, 2025, on a prospective basis. Early adoption is permitted. The Company is currently evaluating the impact of this ASU on its unaudited consolidated financial statements and related disclosures. NOTE 3 – ACCOUNTS RECEIVABLE Accounts receivable consist of the following: SCHEDULE OF ACCOUNTS RECEIVABLE NET September 30, December 31, 2024 2023 Accounts receivable – non-factored $ 3,040,355 $ 2,060,915 Accounts receivable – factored with recourse 305,472 562,767 Total accounts receivable, gross 3,345,827 2,623,682 Less: allowance for credit losses - - Total accounts receivable 3,345,827 2,623,682 Less: current portion ( 2,578,855 ) ( 2,623,682 ) Accounts receivable, non-current $ 766,972 $ - F- 12 NOTE 4 – PREPAID EXPENSES Prepaid expenses consist of the following: SCHEDULE OF PREPAID EXPENSES September 30, December 31, 2024 2023 Prepayments to software and consulting services vendors $ 238,969 $ 199,376 Prepaid marketing and consulting fees 262,514 92,546 Prepaid subscription fees 92,735 95,971 Prepaid insurance premium 81,277 72,668 Others 93,688 76,304 Total $ 769,183 $ 536,865 NOTE 5 – RELATED PARTY TRANSACTIONS As of September 30, 2024 and December 31, 2023, the Company has a due to related party balance of $ 1,438 and $ 1,476 , respectively, from Sumitaka Yamamoto, the Chief Executive Officer (“CEO”) and major shareholder of the Company. The balance is unsecured, non-interest bearing and due on demand. During the nine months ended September 30, 2024, the Company repaid to the related party for operating expenses the related party paid on behalf of the Company in a net amount of $ 7 . During the nine months ended September 30, 2023, the related party paid operating expenses on behalf of the Company and received the payments in a net amount of $ 7,562 . As of September 30, 2024 and December 31, 2023, the Company has a loan receivable balance of $ 190,206 and $ 227,704 , respectively, from Heartcore Technology Inc., a company controlled by the CEO of the Company. The loan was made to the related party to support its operation. The balance is unsecured, bears an annual interest of 1.475 %, and requires repayments in installments starting from February 2022. During the nine months ended September 30, 2024 and 2023, the Company received repayments of $ 31,457 and $ 34,823 , respectively, from this related party. During the nine months ended September 30, 2024, the Company engaged Luvina Software Joint Stock Company, the non-controlling interest shareholder of HeartCore Luvina, for software development and other support services in the amount of $ 150,516 . As of September 30, 2024 and December 31, 2023, the Company has an accounts payable and accrued expenses balance of $ 28,772 and nil , respectively, to this related party. NOTE 6 – INVESTMENTS Investment in SAFE On April 17, 2024, the Company entered into a simple agreement for future equity (“SAFE”) for $ 350,000 with Heart-Tech Health, Inc. (“Heart-Tech”), a non-related company, in exchange for the right to be issued certain shares of Heart-Tech’s preferred stock in connection with Heart-Tech’s future equity financing, at a 15 % discount to the price per share of the preferred stock sold in the equity financing, subject to a pre-determined valuation cap. Alternatively, upon a dissolution or liquidity event such as a change in control or an initial public offering, the Company is entitled to receive a portion of $ 350,000 . As of September 30, 2024, the Company recorded the investment of $ 350,000 as an investment in SAFE on the consolidated balance sheet. Investment in Equity Securities On May 2, 2023, the Company purchased a $ 300,000 promissory note from a non-related company. The note bears an interest rate of 8 % per annum and matures on the earlier of 1) the date of the closing of capital-raising transactions in the amount of $ 300,000 or more consummated by the promissory note issuer, 2) the date on which the promissory note issuer completes its initial public offering on the Nasdaq Capital Market or New York Stock Exchange, or 3) 180 days following the note issuance. The interest rate would be 12 % per annum for any amount that is unpaid when due. On July 27, 2023, the Company entered into a note exchange agreement with the promissory note issuer to convert all of the promissory note principal amount and accrued interest into 600,000 shares of common shares of the promissory note issuer. Investment in Warrants The Company received warrants from its customers as noncash consideration from consulting services. The warrants are not registered for public sale and are initially measured at fair value at contract inception. The Company’s investment in warrants is measured on a recurring basis and carried on the balance sheets at an estimated fair value at the end of the period. The valuation of investment in warrants is determined using the Black-Scholes model based on the stock price, exercise price, expected volatility, time to maturity, and a risk-free interest rate for the term of the warrants exercise. F- 13 The following table summarizes the Company’s investment in warrants activities for the nine months ended September 30, 2024 and 2023: SCHEDULE OF INVESTMENT IN WARRANTS ACTIVITY For the Nine Months Ended September 30, 2024 2023 Fair value of investment in warrants at beginning of the period $ 2,004,308 $ - Warrants received as noncash consideration 12,969,683 4,009,335 Changes in fair value of investment in warrants 1,631,700 ( 294,565 ) Warrants converted to marketable securities ( 6,443,276 ) ( 1,257,868 ) Warrants sold * ( 9,610,628 ) - Fair value of investment in warrants at end of the period $ 551,787 $ 2,456,902 * On February 29, 2024, the Company entered into a warrants transfer agreement with a non-related company to sell partial of the warrants it received from a customer (“Consulting Customer”) as noncash consideration from consulting services for $ 9,000,000 in cash. The warrants to be transferred are exercisable only upon its Consulting Customer’s consummation of the Merger with a special purpose acquisition company or the occurrence of other fundamental events defined in the warrant agreement it had with the Consulting Customer. The Company completed its sale of warrants in September 2024 and recorded $ 3,970,628 in loss on sale of warrants from this transaction. Investments in Marketable Securities The Company’s investments in marketable securities represent stocks received from its customers as noncash consideration from consulting services and stocks received upon the exercise of warrants described above. They are registered for public sale with readily determinable fair values, and are measured at quoted prices on a recurring basis at the end of the period. The following table summarizes the Company’s investments in marketable securities activities for the nine months ended September 30, 2024 and 2023: SCHEDULE OF INVESTMENTS IN MARKETABLE SECURITIES For the Nine Months Ended September 30, 2024 2023 Fair value of investments in marketable securities at beginning of the period $ 642,348 $ - Marketable securities received as noncash consideration 572,010 - Warrants converted to marketable securities 6,443,276 1,257,868 Changes in fair value of investments in marketable securities ( 308,059 ) ( 500,762 ) Marketable securities sold - - Fair value of investments in marketable securities at end of the period $ 7,349,575 $ 757,106 NOTE 7 – LONG-TERM NOTE RECEIVABLE On September 1, 2023, the Company purchased a $ 300,000 promissory note from a non-related company. The note bears an interest rate of 4 % per annum and matures on September 2, 2026 . On the first business day following each annual anniversary of September 1, 2023, the promissory note issuer shall pay to the Company the sum of one-third of the total promissory note amount due and outstanding, including all accrued and unpaid interest as of such time, unless such annual payment has been forgiven by the Company pursuant to certain conditions. The interest rate would be 10 % per annum for any amount that is unpaid when due. As of the date of this report, the Company did not receive the first annual payment from the promissory note issuer. F- 14 NOTE 8 – PROPERTY AND EQUIPMENT, NET Property and equipment, net consist of the following: SCHEDULE OF PROPERTY AND EQUIPMENT NET 2024 2023 September 30, December 31, 2024 2023 Leasehold improvements $ 481,063 $ 496,810 Machinery and equipment 695,635 706,145 Vehicle 88,040 89,859 Software 147,584 150,633 Subtotal 1,412,322 1,443,447 Less: accumulated depreciation ( 748,875 ) ( 679,717 ) Property and equipment, net $ 663,447 $ 763,730 Depreciation expenses are $ 83,534 and $ 70,200 for the nine months ended September 30, 2024 and 2023, respectively. NOTE 9 – INTANGIBLE ASSET, NET Intangible asset, net is as follows: SCHEDULE OF INTANGIBLE ASSETS September 30, December 31, 2024 2023 Customer relationship $ 5,100,000 $ 5,100,000 Less: accumulated amortization ( 1,062,500 ) ( 584,375 ) Intangible asset, net $ 4,037,500 $ 4,515,625 Amortization expenses are $ 478,125 and $ 425,000 for the nine months ended September 30, 2024 and 2023, respectively. As of September 30, 2024, the future estimated amortization cost for intangible asset is as follows: SCHEDULE OF AMORTIZATION INTANGIBLE ASSET Estimated Year Ended December 31, Amortization Remaining of 2024 $ 159,375 2025 637,500 2026 637,500 2027 637,500 2028 637,500 Thereafter 1,328,125 Total $ 4,037,500 NOTE 10 – LEASES The Company has entered into six leases for its office space, one of which was terminated in February 2024, and these leases were classified as operating leases. The Company has also entered into a lease for office equipment and it was terminated in March 2024, and two leases for vehicles, one of which was terminated in September 2023, and these leases were classified as finance leases. Right-of-use assets of these finance leases in the amount of $ 70,432 and $ 85,613 are included in property and equipment, net as of September 30, 2024 and December 31, 2023, respectively. Operating lease expenses for lease payments are recognized on a straight-line basis over the lease term. Finance lease costs include amortization, which are recognized on a straight-line basis over the expected life of the leased assets, and interest expenses, which are recognized following an effective interest rate method. Leases with initial term of twelve months or less are not recorded in the consolidated balance sheets. The components of lease costs are as follows: SCHEDULE OF LEASE COSTS 2024 2023 For the Nine Months Ended September 30, 2024 2023 Finance lease costs Amortization of right-of-use assets $ 12,863 $ 15,215 Interest on lease liabilities 721 98 Total finance lease costs 13,584 15,313 Operating lease costs 299,304 286,934 Total lease costs $ 312,888 $ 302,247 F- 15 The following table presents supplemental information related to the Company’s leases: SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO COMPANY’S LEASES 2024 2023 For the Nine Months Ended September 30, 2024 2023 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from finance leases $ 721 $ 98 Operating cash flows from operating leases 306,756 257,277 Financing cash flows from finance leases 12,568 16,537 Finance lease right-of-use assets obtained in exchange for finance lease liabilities - 93,117 Operating lease right-of-use assets obtained in exchange for operating lease liabilities 125,735 317,040 Remeasurement of operating lease liabilities and right-of-use assets due to lease modification - 12,579 Weighted average remaining lease term (years) Finance leases 4.0 5.0 Operating leases 7.1 7.7 Weighted average discount rate (per annum) Finance leases 1.32 % 1.32 % Operating leases 1.36 % 1.33 % As of September 30, 2024, the future maturity of lease liabilities is as follows: SCHEDULE OF FINANCE LEASE AND OPERATING LEASE FUTURE MATURITY OF LEASE LIABILITIES Year Ended December 31, Finance Lease Operating Lease Remaining of 2024 $ 4,545 $ 107,999 2025 18,179 403,889 2026 18,179 329,040 2027 18,179 283,512 2028 12,119 283,512 Thereafter - 942,387 Total lease payments 71,201 2,350,339 Less: imputed interest ( 1,821 ) ( 107,797 ) Total lease liabilities 69,380 2,242,542 Less: current portion ( 17,375 ) ( 382,594 ) Non-current lease liabilities $ 52,005 $ 1,859,948 Pursuant to the operating lease agreements, the Company made security deposits to the lessors. The security deposits amount to $ 336,117 and $ 348,428 as of September 30, 2024 and December 31, 2023, respectively. NOTE 11 – OTHER CURRENT LIABILITIES Other current liabilities consist of the following: SCHEDULE OF OTHER CURRENT LIABILITIES September 30, December 31, 2024 2023 Accrued consumption taxes $ 228,630 $ 143,702 Customer refund liability * 500,000 - Others 28,136 72,703 Total other current liabilities $ 756,766 $ 216,405 * On June 28, 2024, the Company entered into a settlement agreement with a customer, pursuant to which the consulting service agreement with the customer was terminated and the Company will refund $ 500,000 to the customer in August 2025. F- 16 NOTE 12 – FACTORING LIABILITY Sigmaways, the subsidiary acquired by the Company in February 2023, entered into a factoring and security agreement (“Factoring Agreement”) with The Southern Bank Company, an unrelated factor (the “Factor”), in 2017, for the purpose of factoring certain accounts receivable. Under the terms of the Factoring Agreement, the Company may offer for sale, and the Factor may purchase in its sole discretion, certain accounts receivable of the Company (the “Purchased Receivable”). The Factoring Agreement provided for a maximum of $ 850,000 in Purchased Receivable. Selected accounts receivable is submitted to the Factor, and the Company receives 90 % of the face value of the accounts receivable by wire transfer. Upon payment by the customers, the remainder of the amount due is received from the Factor after deducting certain fees. The Factoring Agreement specifies that eligible accounts receivable is factored with recourse. Under the terms of the recourse provision, the Company is required to reimburse the Factor, upon demand, for Purchased Receivable that is not paid on time by the customers. The performance of all obligations and payments to the Factor is personally guaranteed by Prakash Sadasivam, CEO of Sigmaways and Chief Strategy Officer (“CSO”) of the Company, and secured by all Sigmaways’ now owned and hereafter assets and any sums maintained by the Factor that are identified as payable to the Company. The Factoring Agreement has an initial term of twelve months and automatically renews for successive twelve-month renewal periods unless terminated pursuant to the terms of the Factoring Agreement. The Company may terminate the Factoring Agreement with sixty days’ written notice to the Factor and is subject to certain early termination fee. The Factoring Agreement contained covenants that are customary for accounts receivable-based factoring agreements and also contained provisions relating to events of default that are customary for agreements of this type. As of September 30, 2024 and December 31, 2023, there was $ 305,472 and $ 562,767 borrowed and outstanding under the Factoring Agreement, respectively. There are various fees charged by the Factor, including initial discount purchase fee, factoring fee and interest expense. During the nine months ended September 30, 2024 and 2023, the Company recorded $ 38,706 and $ 54,790 in interest expenses related to the Factoring Agreement, respectively. NOTE 13 – INSURANCE PREMIUM FINANCING In January 2024, the Company entered into an insurance premium financing agreement with BankDirect Capital Finance for $ 172,689 at an annual interest rate of 13.9 % for eleven months from February 1, 2024, payable in eleven monthly installments of principal and interest. In January 2023, the Company entered into an insurance premium financing agreement with BankDirect Capital Finance for $ 389,035 at an annual interest rate of 16.04 % for ten months from February 1, 2023, payable in ten monthly installments of principal and interest. As of September 30, 2024 and December 31, 2023, the balances of the insurance premium financing were $ 65,392 and nil , respectively. During the nine months ended September 30, 2024 and 2023, the Company recorded $ 10,380 and $ 25,988 , respectively, in interest expenses related to the insurance premium financing. F- 17 NOTE 14 – DEBTS Short-term Debt The Company’s short-term debt represents a loan borrowed from a financial institution as follows: SCHEDULE OF SHORT-TERM DEBTS Name of Financial Institution Original Amount Borrowed Loan Duration Annual Interest Rate Balance as of September 30, 2024 Balance as of December 31, 2023 Biz Forward Co., Ltd. JPY 19,280,001 (a) 12/26/2023 – 1/31/2024 36.840 % $ - $ 135,937 (a) The loan is secured by accounts receivable of HeartCore Japan in the amount of JPY 23,882,562 . Long-term Debts The Company’s long-term debts included bond payable and loans borrowed from banks and financial institutions, which consist of the following: SCHEDULE OF LONG-TERM DEBTS Name of Banks/Financial Institutions Original Amount Borrowed Loan Duration Annual Interest Rate Balance as of September 30, 2024 Balance as of December 31, 2023 Bond payable Corporate bond issued through Resona Bank, Limited JPY 100,000,000 (b)(d) 1/10/2019 – 1/10/2024 0.430 % $ - $ 70,507 Loans with banks and financial institutions Resona Bank, Limited JPY 50,000,000 (b)(c) 12/29/2017 – 12/29/2024 0.675 % 23,176 54,678 Resona Bank, Limited JPY 10,000,000 (b)(c) 9/30/2020 – 9/30/2027 1.000 % 34,056 38,624 Resona Bank, Limited JPY 40,000,000 (b)(c) 9/30/2020 – 9/30/2027 1.000 % 136,225 154,495 Resona Bank, Limited JPY 20,000,000 (b)(c) 11/13/2020 – 10/31/2027 1.600 % 69,757 78,925 Sumitomo Mitsui Banking Corporation JPY 100,000,000 (b) 12/28/2018 – 7/1/2024 1.475 % - 11,612 Sumitomo Mitsui Banking Corporation JPY 10,000,000 (b)(c) 12/30/2019 – 12/30/2026 1.975 % 26,492 31,072 Sumitomo Mitsui Banking Corporation JPY 10,000,000 (b)(c) 10/4/2023 – 9/30/2028 0.600 % 61,633 68,152 Sumitomo Mitsui Banking Corporation JPY 10,000,000 (b)(c) 10/4/2023 – 9/30/2028 0.000 % 61,633 68,152 The Shoko Chukin Bank, Ltd. JPY 50,000,000 7/27/2020 – 6/30/2027 1.290 % 163,028 183,319 The Shoko Chukin Bank, Ltd. JPY 30,000,000 7/25/2023 – 6/30/2028 Tokyo Interbank Offered Rate + 1.950 % 179,055 197,137 Japan Finance Corporation JPY 80,000,000 11/17/2020 – 11/30/2027 0.210 % 294,004 327,152 Higashi-Nippon Bank JPY 30,000,000 (b) 3/31/2022 – 3/31/2025 1.400 % 67,975 93,070 Higashi-Nippon Bank JPY 30,000,000 (b)(c) 10/11/2023 – 9/30/2028 1.450 % 186,516 204,471 First Home Bank $ 350,000 (e) 4/18/2019 – 4/18/2029 Wall Street Journal U.S. Prime Rate + 2.750 % 204,522 229,007 U.S. Small Business Administration $ 350,000 (e) 5/30/2020 – 5/30/2050 3.750 % 350,000 350,000 Aggregate outstanding principal balances 1,858,072 2,160,373 Less: unamortized debt issuance costs ( 13,903 ) ( 18,238 ) Less: current portion ( 462,121 ) ( 371,783 ) Non-current portion $ 1,382,048 $ 1,770,352 (b) These debts are guaranteed by Sumitaka Yamamoto, the Company’s CEO and major shareholder. (c) These debts are guaranteed by Tokyo Credit Guarantee Association, and the Company has paid guarantee expenses for these debts. (d) The bond is guaranteed by Resona Bank, Limited. (e) These debts are guaranteed by Prakash Sadasivam, CEO of Sigmaways and CSO of the Company, and secured by all assets of Sigmaways. F- 18 Interest expense for short-term debt and long-term debts was $ 3,245 and $ 52,763 , respectively, for the nine months ended September 30, 2024. Interest expense for short-term debt and long-term debts was nil and $ 44,295 , respectively, for the nine months ended September 30, 2023. As of September 30, 2024, future minimum principal payments for long-term debts are as follows: SCHEDULE OF FUTURE MINIMUM LOAN PAYMENTS Principal Year Ended December 31, Payment Remaining of 2024 $ 99,325 2025 434,474 2026 386,063 2027 414,474 2028 187,152 Thereafter 336,584 Total $ 1,858,072 NOTE 15 – INCOME TAXES United States HeartCore USA, Sigmaways and HeartCore Financial, incorporated in the United States, are subject to federal income tax at 21 % statutory tax rate with respect to the profit generated from the United States. Netherlands Sigmaways B.V. is a company incorporated in Netherlands in November 2019. The first EUR200,000 of taxable income is subject to a statutory tax rate of 19 % and the remaining taxable income is subject to a statutory tax rate of 25.80 %. Canada Sigmaways Technologies is a company incorporated in British Columbia in Canada in August 2020. It is subject to income tax on income arising in, or derived from, the tax jurisdiction in British Columbia it operates. The basic federal rate of Part I tax is 38 % of taxable income, 28 % after federal tax abatement. After the general tax reduction, the net federal tax rate is 15 %. The provincial and territorial lower and higher tax rates in British Columbia are 2 % and 12 %, respectively. Vietnam HeartCore Luvina is a company incorporated in Vietnam in November 2023. It is subject to standard income tax rate at 20 % with respect to the taxable income. Japan The Company conducts its major businesses in Japan and is subject to tax in this jurisdiction. As a result of its business activities, the Company files tax returns that are subject to examination by the local tax authority. Income taxes in Japan applicable to the Company are imposed by the national, prefectural and municipal governments, and in the aggregate result in an effective statutory tax rate of approximately 34.59 % for the nine months ended September 30, 2024 and 2023. For the nine months ended September 30, 2024 and 2023, the Company’s income tax expense are as follows: SCHEDULE OF INCOME TAX EXPENSES 2024 2023 For the Nine Months Ended September 30, 2024 2023 Current $ 236,144 $ 168,549 Deferred ( 163,199 ) ( 109,690 ) Income tax expense $ 72,945 $ 58,859 The effective tax rate was 1.01 % and ( 3.47 )% for the nine months ended September 30, 2024 and 2023, respectively. NOTE 16 – STOCK-BASED COMPENSATION Options On August 6, 2021, the Board of Directors and shareholders of the Company approved a 2021 Equity Incentive Plan (the “2021 Plan”), under which 2,400,000 shares of common shares are authorized for issuance. On February 3, 2023, the Company awarded options to purchase 100,000 shares of common shares pursuant to the 2021 Plan at an exercise price of $ 1.17 per share to an employee of the Company. The options vest 50 % on the grant date and February 1, 2024, respectively, with the expiration date on February 3, 2033 . On August 25, 2023, the Company awarded options to purchase 2,000 shares of common shares pursuant to the 2021 Plan at an exercise price of $ 1.10 per share to an employee of the Company. The options vest on each annual anniversary of the date of issuance, in an amount equal to 25 % of the applicable shares of common shares, with the expiration date on August 25, 2033 . On August 1, 2023, the Board of Directors of the Company approved a 2023 Equity Incentive Plan (the “2023 Plan”), under which 2,000,000 shares of common shares are authorized for issuance. No shares were issued pursuant to the 2023 Plan as of September 30, 2024. F- 19 The following table summarizes the stock options activity and related information for the nine months ended September 30, 2024 and 2023: SCHEDULE OF STOCK OPTION ACTIVITY Number of Options Weighted Average Exercise Price Weighted Average Remaining Term (Years) Intrinsic Value As of January 1, 2023 1,466,500 $ 2.50 8.94 $ - Granted 102,000 1.17 9.36 - Exercised -         - - - Forfeited ( 9,500 ) 2.50 - - As of September 30, 2023 1,559,000 $ 2.41 8.27 $ - As of January 1, 2024 1,547,000 $ 2.41 8.01 $ - Granted - - - - Exercised - - - - Forfeited ( 35,000 ) 2.42 - - As of September 30, 2024 1,512,000 $ 2.41 7.26 $ - Vested and exercisable as of September 30, 2024 813,250 $ 2.34 7.28 $ - The Company calculated the fair value of options granted in the nine months ended September 30, 2023 using the Black-Scholes model. Significant assumptions used in the valuation include expected volatility, risk-free interest rate, dividend yield and expected exercise term. For the three and nine months ended September 30, 2024, the Company recognized stock-based compensation related to options of $ 73,457 and $ 184,501 , respectively. For the three and nine months ended September 30, 2023, the Company recognized stock-based compensation related to options of $ 144,306 and $ 479,122 , respectively. The outstanding unamortized stock-based compensation related to options was $ 192,773 (which will be recognized through December 2025) as of September 30, 2024. Restricted Stock Units (“RSUs”) On March 22, 2023, the Company entered into agreements with employees and service providers of Sigmaways and granted 671,350 RSUs pursuant to the 2021 Plan. The RSUs were fully vested upon issuance. The fair value of the RSUs at grant date was $ 691,491 . The following table summarizes the RSUs activity for the nine months ended September 30, 2024 and 2023: SCHEDULE OF RESTRICTED STOCK UNITS Number of RSUs Weighted Average Grant Date Fair Value Per Share Unvested as of January 1, 2023 85,820 $ 4.95 Granted 671,350 1.03 Vested ( 692,804 ) 1.15 Forfeited - - Unvested as of September 30, 2023 64,366 $ 4.95 Unvested as of January 1, 2024 64,366 $ 4.95 Granted - - Vested ( 21,454 ) 4.95 Forfeited - - Unvested as of September 30, 2024 42,912 $ 4.95 For the three and nine months ended September 30, 2024, the Company recognized stock-based compensation related to RSUs of $ 15,615 and $ 52,325 , respectively. For the three and nine months ended September 30, 2023, the Company recognized stock-based compensation related to RSUs of $ 29,000 and $ 788,577 , respectively. The outstanding unamortized stock-based compensation related to RSUs was $ 48,785 (which will be recognized through February 2026) as of September 30, 2024. F- 20 NOTE 17 – SHAREHOLDERS’ EQUITY On February 1, 2023, 2,500,000 shares of common shares were issued for the acquisition of 51 % of the outstanding shares of Sigmaways and its subsidiaries with fair value of $ 3,150,000 (also see NOTE 19). In November 2023, the Company established a 51 % owned subsidiary in Vietnam. On February 16, 2024, the Company received capital contribution of VND 1,646.4 million in cash, equivalent to $ 67,195 , from the non-controlling shareholder of the subsidiary. On March 29, 2024, the Board of Directors approved a dividend declaration of $ 0.02 per share of common share for the shareholders of record at the close of business on April 26, 2024. The dividends in the amount of $ 417,283 were paid on May 3, 2024. On July 22, 2024, the Board of Directors approved a dividend declaration of $ 0.02 per share of common share for the shareholders of record at the close of business on August 19, 2024. The dividends in the amount of $ 417,283 were paid on August 26, 2024. As of September 30, 2024 and December 31, 2023, there were 20,864,144 and 20,842,690 shares of common shares issued and outstanding, respectively. No preferred shares were issued and outstanding as of September 30, 2024 and December 31, 2023. NOTE 18 – NET INCOME (LOSS) PER SHARE Basic net income (loss) per share is calculated on the basis of weighted average outstanding common shares. Diluted net income (loss) per share is computed on the basis of basic weighted average outstanding common shares adjusted for the dilutive effect of stock options, RSUs and other dilutive securities. Common shares equivalents are determined by applying the treasury stock method to the assumed conversion of share repurchase liability to common shares related to the early exercised stock options and unvested RSUs, and are not included in the calculation of diluted income (loss) per share if their effect would be anti-dilutive. The computation of basic and diluted net income (loss) per share for the three and nine months ended September 30, 2024 and 2023 is as follows: SCHEDULE OF COMPUTATION OF BASIC AND DILUTED EARNINGS (LOSS) PER SHARE 2024 2023 2024 2023 For the Three Months Ended September 30, For the Nine Months Ended September 30, 2024 2023 2024 2023 Net income (loss) per share – basic and diluted Numerator Net income (loss) attributable to HeartCore Enterprises, Inc. common shareholders $ 11,057,806 $ ( 2,307,220 ) $ 7,773,356 $ ( 1,336,731 ) Denominator Weighted average number of common shares outstanding used in calculating net income (loss) per share 20,864,144 20,842,690 20,861,012 20,257,020 Net income (loss) per share – basic and diluted $ 0.53 $ ( 0.11 ) $ 0.37 $ ( 0.07 ) For the three and nine months ended September 30, 2024 and 2023, the weighted average common shares outstanding are the same for basic and diluted net income (loss) per share calculations, as the inclusion of common share equivalents would have an anti-dilutive effect. F- 21 NOTE 19 – BUSINESS COMBINATION On September 6, 2022, HeartCore USA entered into the Sigmaways Agreement to acquire 51 % of the outstanding shares of Sigmaways, a company incorporated under the laws of the State of California, and its subsidiaries. The Sigmaways Agreement was further amended on December 23, 2022 and February 1, 2023, respectively, and the transaction was closed on February 1, 2023. The purchase consideration is $ 4,150,000 , consisted of $ 1,000,000 in cash and 2,500,000 shares of common shares of the Company with fair value of $ 3,150,000 at the closing date. The total purchase price is allocated to the tangible and identifiable intangible assets acquired and liabilities assumed and non-controlling interest based on their estimated fair values as of the acquisition date. The excess of the purchase price over those fair values is recorded as goodwill. The purchase price is allocated on the acquisition date as follows: SCHEDULE OF BUSINESS PURCHASE PRICE ALLOCATION Amount Current assets $ 2,066,683 Acquired intangible asset 5,100,000 Non-current assets 47,979 Current liabilities ( 1,146,900 ) Deferred tax liabilities ( 1,428,000 ) Non-current liabilities ( 576,203 ) Goodwill 3,276,441 Non-controlling interest ( 3,190,000 ) Total purchase consideration $ 4,150,000 The results of operations, financial position and cash flows of Sigmaways and its subsidiaries have been included in the Company’s unaudited consolidated financial statements since the date of acquisition. Pro forma results of operations for the business combination have not been presented because they are not material to the unaudited consolidated statements of operations and comprehensive income (loss). The Company’s policy is to perform its annual impairment testing on goodwill for its reporting unit on December 31 of each fiscal year or more frequently if events or changes in circumstances indicate that an impairment may exist. The Company did not recognize any impairment loss on goodwill for the nine months ended September 30, 2024 and 2023. NOTE 20 – SUBSEQUENT EVENTS On October 1, 2024, the Company granted 69,653 RSUs pursuant to the 2023 Plan to four executives of the Company. The RSUs were fully vested upon issuance. On October 8, 2024, the Company entered into share transfer agreements with multiple third parties to sell 2,304 stocks obtained through exercise of stock warrants of a consulting service customer for approximately $ 400,000 . F- 22 ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The Private Securities Litigation Reform Act of 1995 and Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), provide a safe harbor for forward-looking statements made by us or on our behalf. We and our representatives may from time to time make written or oral statements that are “forward-looking,” including statements contained in this report and other filings with the Securities and Exchange Commission (“SEC”) and in our reports and presentations to stockholders or potential stockholders. In some cases, forward-looking statements can be identified by words such as “believe,” “expect,” “anticipate,” “plan,” “potential,” “continue” or similar expressions. Such forward-looking statements include risks and uncertainties and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks and uncertainties can be found in Part I, Item 1A, “Risk Factors,” of our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, as the same may be updated from time to time, including in Part II, Item 1A, “Risk Factors,” of this Quarterly Report on Form 10-Q. Although we believe the expectations reflected in our forward-looking statements are based upon reasonable assumptions, it is not possible to foresee or identify all factors that could have a material effect on the future financial performance of the Company. The forward-looking statements in this report are made on the basis of management’s assumptions and analyses, as of the time the statements are made, in light of their experience and perception of historical conditions, expected future developments and other factors believed to be appropriate under the circumstances. Except as otherwise required by the federal securities laws, we disclaim any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained in this Quarterly Report on Form 10-Q and the information incorporated by reference in this Quarterly Report on Form 10-Q to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any statement is based. Business Overview We are a leading software development company based in Tokyo, Japan. We provide software through two business units. The first business unit, our CX division, includes a customer experience management business (the “CXM Platform”) that has been in existence for 15 years. Our CXM Platform includes marketing, sales, service and content management systems, as well as other tools and integrations, that enable companies to attract and engage customers throughout the customer experience. We also provide education, services and support to help customers be successful with our CXM Platform. The second business unit, our DX division, is a digital transformation business which provides customers with robotics process automation, process mining and task mining to accelerate the digital transformation of enterprises. We also have an ongoing technology innovation team to develop software that supports the narrow needs of large enterprise customers. During 2022, we started the GO IPO business, which supports Japanese companies listing on The Nasdaq Stock Market and the New York Stock Exchange in the United States. As of November 14, 2024, we have entered into consulting agreements with 14 companies to assist them in their IPO process, pursuant to which we are entitled to receive from each company a consulting fee that ranges from $380,000 to $900,000 and warrants or stock acquisition rights to purchase 1% to 4% of the fully-diluted share capital of such companies that is exercisable on certain dates at an exercise price of $0.01 or JPY1 per share. 3 We were incorporated in the State of Delaware on May 18, 2021. We conduct business activities principally through our wholly owned subsidiary, HeartCore Co., Ltd. (“HeartCore Japan”), a Japanese corporation, which was established in Japan by Mr. Sumitaka Yamamoto, our CEO, in 2009. On September 6, 2022, the Company entered into a share exchange and purchase agreement (“Sigmaways Agreement”) to acquire 51% of the outstanding shares of Sigmaways, a company incorporated under the laws of the State of California, and its wholly owned subsidiaries. Sigmaways and its wholly owned subsidiaries are engaged in the business of developing and sales of software in the United States. The acquisition closed on February 1, 2023. In the first quarter of 2023, we formed HeartCore Financial, Inc. (“HeartCore Financial”) in the U.S. and HeartCore Capital Advisors, Inc. (“HeartCore Capital Advisors”) in Japan, as a part of our GO IPO consulting business. In the fourth quarter of 2023, we formed HeartCore Luvina Vietnam Company Limited in Vietnam (“HeartCore Luvina”), which is engaged in the business of software development. On November 17, 2023, HeartCore Japan and HeartCore Capital Advisors entered into a merger agreement to merge the two entities into one with HeartCore Japan being the surviving entity. On January 1, 2024, the merger was completed and HeartCore Capital Advisors transferred all of its assets and liabilities to HeartCore Japan. The merger has been accounted for as a recapitalization between entities under common control since the same controlling shareholders controlled the two entities before and after the transaction. In April 2024, HeartCore Financial incorporated a branch office, HeartCore Financial, Inc. – Japan Branch Office, in Japan. Recent Developments Sale of Warrants On February 29, 2024, the Company entered into a warrants transfer agreement with a non-related company to sell partial of the warrants it received from a customer (“Consulting Customer”) as noncash consideration from consulting services for $9,000,000 in cash. The warrants to be transferred are exercisable only upon its Consulting Customer’s consummation of the Merger with a special purpose acquisition company or the occurrence of other fundamental events defined in the warrant agreement it had with the Consulting Customer. The Company completed its sale of warrants in September 2024 and recorded $3,970,628 in loss on sale of warrants from this transaction. Cash Dividends On March 29, 2024, the Board of Directors of the Company declared a cash dividend of $0.02 per share of the Company’s common shares. The dividend was paid on May 3, 2024 to shareholders of record as of April 26, 2024, resulting in an aggregate of $417,283 in total dividends paid by the Company. On July 22, 2024, the Board of Directors of the Company declared a cash dividend of $0.02 per share of the Company’s common shares. The dividend was paid on August 26, 2024 to shareholders of record as of August 19, 2024, resulting in an aggregate of $417,283 in total dividends paid by the Company. 4 The Company may continue to issue quarterly dividends going forward, contingent upon Board of Directors approval, following review of the Company’s then-current financial results. Future dividends, if any, may be less than, equal to or greater than recent dividends. Noncompliance with Nasdaq’s Minimum Bid Price Requirement On October 26, 2023, the Company received written notice (the “Bid Price Notice”) from the Nasdaq Listing Qualifications Department (the “Nasdaq Staff”) indicating that the Company was not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”) for continued listing on the Nasdaq Capital Market. The notification of noncompliance had no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Capital Market under the symbol “HTCR,” and the Company continued to monitor the closing bid price of its common stock and evaluate its alternatives, if appropriate, to resolve the deficiency and regain compliance with this rule. The Nasdaq Listing Rules require listed securities to maintain a minimum bid price of $1.00 per share and, as of October 26, 2023, based upon the closing bid price for the then-last 30 consecutive business days, the Company no longer met this requirement. The Bid Price Notice indicated that the Company would be provided 180 calendar days, or until April 23, 2024, in which to regain compliance. If at any time during this period the closing bid price of the Company’s common stock is at least $1.00 per share for a minimum of 10 consecutive business days, the Nasdaq Staff would provide the Company with written confirmation of compliance and the matter will be closed. Alternatively, if the Company failed to regain compliance with Rule 5550(a)(2) prior to the expiration of the 180 calendar day period, but met the continued listing requirement for market value of publicly held shares and all of the other applicable standards for initial listing on the Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and provided written notice of its intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary, then the Company may be granted an additional 180 calendar days to regain compliance with Rule 5550(a)(2). On April 24, 2024, the Company received written notice (the “April 2024 Nasdaq Letter”) from the Nasdaq Staff indicating that although the Company was not in compliance with the Minimum Bid Price Requirement, the Nasdaq Staff determined that the Company was eligible for an additional 180 calendar day period, or until October 21, 2024, to regain compliance. The Nasdaq Staff indicated that its determination was based on the Company meeting the continued listing requirement for market value of publicly held shares and all of the other applicable requirements for initial listing on the Nasdaq Capital Market, with the exception of the Minimum Bid Requirement, and the Company’s written notice of its intention to cure the deficiency during the second compliance period by effectuating a reverse stock split, if necessary. Accordingly, there was no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Capital Market under the symbol “HTCR.” If at any time between April 24, 2024 and October 21, 2024, the closing bid price of the Company’s common stock was at least $1.00 per share for a minimum of 10 consecutive business days, the Nasdaq Staff would provide the Company with written confirmation of compliance and the matter would be closed. On October 22, 2024, the Company received written notice (the “October 2024 Nasdaq Notice”) from the Nasdaq Staff indicating that the Company was not in compliance with the Minimum Bid Price Requirement. Pursuant to the October 2024 Nasdaq Notice, unless the Company requests an appeal of the determination to delist the Company’s common stock by October 29, 2024, trading of the Company’s common stock will be suspended at the opening of business on October 31, 2024, and a Form 25-NSE will be filed with the SEC which will remove the Company’s securities from listing and registration on Nasdaq. The Company appealed the determination on October 29, 2024. Submission of the hearing request stayed the suspension of the Company’s securities and the filing of the Form 25-NSE pending the Panel’s decision. On November 5, 2024, the Company received written notice from the Nasdaq Staff that the Company demonstrated compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market. As a result, the hearing appealed on October 29, 2024 has now been cancelled as the Company regained compliance with the Nasdaq Capital Market’s listing requirements. 5 Financial Overview For the three months ended September 30, 2024 and 2023, we generated revenues of $17,850,411 and $4,688,908, respectively, reported a net income of $10,816,930 and a net loss of $2,541,133, respectively. For the nine months ended September 30, 2024 and 2023, we generated revenues of $26,963,531 and $18,518,431, respectively, reported a net income of $7,127,810 and a net loss of $1,755,942, respectively, and had cash flows used in operating activities of $3,499,514 and $2,457,661, respectively. As noted in our unaudited consolidated financial statements, as of September 30, 2024, we had an accumulated deficit of $6,990,113. Results of Operations Comparison of Results of Operations for the Three Months Ended September 30, 2024 and 2023 The following table summarizes our operating results as reflected in our unaudited statements of operations during the three months ended September 30, 2024 and 2023, respectively, and provides information regarding the dollar and percentage increase (or decrease) during such periods. For the Three Months Ended September 30, 2024 2023 Variance % of % of Amount Revenues Amount Revenues Amount % Revenues $ 17,850,411 100.0 % $ 4,688,908 100.0 % $ 13,161,503 280.7 % Cost of revenues 3,433,024 19.2 % 3,860,241 82.3 % (427,217 ) -11.1 % Gross profit 14,417,387 80.8 % 828,667 17.7 % 13,588,720 1,639.8 % Operating expenses: Selling expenses 243,110 1.4 % 274,043 5.9 % (30,933 ) -11.3 % General and administrative expenses 1,966,717 11.0 % 2,172,298 46.3 % (205,581 ) -9.5 % Research and development expenses 107,529 0.6 % 170,071 3.6 % (62,542 ) -36.8 % Total operating expenses 2,317,356 13.0 % 2,616,412 55.8 % (299,056 ) -11.4 % Income (loss) from operations 12,100,031 67.8 % (1,787,745 ) -38.1 % 13,887,776 -776.8 % Other expenses (1,057,826 ) -5.9 % (733,975 ) -15.7 % (323,851 ) 44.1 % Income (loss) before income tax provision 11,042,205 61.9 % (2,521,720 ) -53.8 % 13,563,925 -537.9 % Income tax expense 225,275 1.3 % 19,413 0.4 % 205,862 1,060.4 % Net income (loss) 10,816,930 60.6 % (2,541,133 ) -54.2 % 13,358,063 -525.7 % Less: net loss attributable to non-controlling interests (240,876 ) -1.3 % (233,913 ) -5.0 % (6,963 ) 3.0 % Net income (loss) attributable to HeartCore Enterprises, Inc. $ 11,057,806 61.9 % $ (2,307,220 ) -49.2 % $ 13,365,026 -579.3 % 6 Revenues Our total revenues increased by $13,161,503, or 280.7%, to $17,850,411 for the three months ended September 30, 2024 from $4,688,908 for the three months ended September 30, 2023, mainly attributable to the increased revenues of $13,272,315 from GO IPO consulting services as two of the Company’s GO IPO customers successfully listed on the Nasdaq in the third quarter of 2024 and the Company recognized revenues from noncash consideration in the form of warrants and ordinary shares from the consulting services customers. Cost of Revenues Our total costs of revenues decreased by $427,217, or 11.1%, to $3,433,024 for the three months ended September 30, 2024 from $3,860,241 for the three months ended September 30, 2023, primarily attributable to (i) a decrease of $238,701 in the costs of GO IPO consulting services in line with the decrease in revenues of GO IPO consulting services by excluding th e amount recognized from noncash consideration; (ii) a decrease of $219,058 in the costs of customized software development and services in light of the decrease in sales. Gross Profit Our total gross profit increased by $13,588,720, or 1,639.8%, to $14,417,387 for the three months ended September 30, 2024 from $828,667 for the three months ended September 30, 2023, mainly attributable to an increase in gross profit of $13,511,016 from GO IPO consulting services as the Company recognized revenues from noncash consideration in the form of warrants and ordinary shares from two of IPO customers upon their IPO effectiveness with no associated costs in the three months ended September 30, 2024, while there was no such event during the three months ended September 30, 2023 . For the reason discussed above, our overall gross profit margin increased by 63.1% to 80.8% for the three months ended September 30, 2024 from 17.7% for the three months ended September 30, 2023. Selling Expenses Our selling expenses decreased by $30,933, or 11.3%, to $243,110 for the three months ended September 30, 2024 from $274,043 in the three months ended September 30, 2023, primarily attributable to a decrease of $41,224 in stock-based compensation as the Company granted shares of common stock to employees and service providers of Sigmaways in 2023, and there was no such event in the current period. As a percentage of revenues, our selling expenses accounted for 1.4% and 5.9% of our total revenues for the three months ended September 30, 2024 and 2023, respectively. General and Administrative Expenses Our general and administrative expenses decreased by $205,581, or 9.5%, to $1,966,717 for the three months ended September 30, 2024 from $2,172,298 in the three months ended September 30, 2023, primarily attributable to a decrease of $230,045 in salaries and welfare due to the retirement of certain employees. As a percentage of revenues, our general and administrative expenses were 11.0% and 46.3% of our total revenues for the three months ended September 30, 2024 and 2023, respectively. Research and Development Expenses Our research and development expenses decreased by $62,542, or 36.8%, to $107,529 in the three months ended September 30, 2024 from $170,071 in the three months ended September 30, 2023, primarily attributable to a decrease of $61,986 in outsourcing expenses relating to the development of new CMS management screen features which will be completed soon. As a percentage of revenues, our research and development expenses were 0.6% and 3.6% of our total revenues for the three months ended September 30, 2024 and 2023, respectively. 7 Other Income (Expenses), Net Our other income (expenses) primarily includes changes in fair value of investments in marketable securities, changes in fair value of investment in warrants, loss on sale of warrants, interest income generated from bank deposits, interest expense for bank loans and bond, other income, and other expenses. Other expenses, net, of $733,975 for the three months ended September 30, 2023 increased by $323,851, or 44.1%, to other expenses, net, of $1,057,826 for the three months ended September 30, 2024, primarily attributable to (i) a loss of $3,970,628 on sale of warrants, offset (ii) by an increase of $3,330,079 in changes in fair value of investment in warrants and (iii) an increase of $394,012 in changes in fair value of investments in marketable securities. Income Tax Expense Income tax expense was $225,275 in the three months ended September 30, 2024, an increase of $205,862, or 1,060.4%, from income tax expense of $19,413 in the three months ended September 30, 2023, primarily due to a net income before income tax provision in the current period, while we recorded a net loss before income tax provision in the three months ended September 30, 2023. Net Income (Loss) As a result of the foregoing, we reported a net income of $10,816,930 for the three months ended September 30, 2024, representing a $13,358,063, or 525.7%, increase from a net loss of $2,541,133 for the three months ended September 30, 2023. Net Loss Attributable to Non-controlling Interests We owned 51% equity interest in Sigmaways and its subsidiaries and 51% equity interest in HeartCore Luvina. Accordingly, we recorded net loss attributable to non-controlling interests of $240,876 and $233,913 for the three months ended September 30, 2024 and 2023, respectively. Net Income (Loss) Attributable to HeartCore Enterprises, Inc. As a result of the foregoing, we reported a net income attributable to HeartCore Enterprises, Inc. of $11,057,806 for the three months ended September 30, 2024, representing a $13,365,026, or 579.3%, increase from a net loss attributable to HeartCore Enterprises, Inc. of $2,307,220 for the three months ended September 30, 2023. 8 Comparison of Results of Operations for the Nine Months Ended September 30, 2024 and 2023 The following table summarizes our operating results as reflected in our unaudited statements of operations during the nine months ended September 30, 2024 and 2023, respectively, and provides information regarding the dollar and percentage increase (or decrease) during such periods. For the Nine Months Ended September 30, 2024 2023 Variance % of % of Amount Revenues Amount Revenues Amount % Revenues $ 26,963,531 100.0 % $ 18,518,431 100.0 % $ 8,445,100 45.6 % Cost of revenues 9,708,074 36.0 % 10,548,245 57.0 % (840,171 ) -8.0 % Gross profit 17,255,457 64.0 % 7,970,186 43.0 % 9,285,271 116.5 % Operating expenses: Selling expenses 642,225 2.4 % 1,330,747 7.2 % (688,522 ) -51.7 % General and administrative expenses 6,395,429 23.8 % 7,305,392 39.4 % (909,963 ) -12.5 % Research and development expenses 307,931 1.1 % 289,303 1.6 % 18,628 6.4 % Total operating expenses 7,345,585 27.3 % 8,925,442 48.2 % (1,579,857 ) -17.7 % Income (loss) from operations 9,909,872 36.7 % (955,256 ) -5.2 % 10,865,128 -1,137.4 % Other expenses (2,709,117 ) -10.0 % (741,827 ) -4.0 % (1,967,290 ) 265.2 % Income (loss) before income tax provision 7,200,755 26.7 % (1,697,083 ) -9.2 % 8,897,838 -524.3 % Income tax expense 72,945 0.3 % 58,859 0.3 % 14,086 23.9 % Net income (loss) 7,127,810 26.4 % (1,755,942 ) -9.5 % 8,883,752 -505.9 % Less: net loss attributable to non-controlling interests (645,546 ) -2.4 % (419,211 ) -2.3 % (226,335 ) 54.0 % Net income (loss) attributable to HeartCore Enterprises, Inc. $ 7,773,356 28.8 % $ (1,336,731 ) -7.2 % $ 9,110,087 -681.5 % Revenues Our total revenues increased by $8,445,100, or 45.6%, to $26,963,531 for the nine months ended September 30, 2024 from $18,518,431 for the nine months ended September 30, 2023, mainly attributable to the increased revenues of $8,168,414 from GO IPO consulting services as two of the Company’s GO IPO customers successfully listed on the Nasdaq in the third quarter of 2024 and the Company recognized revenues from noncash consideration in the form of warrants and ordinary shares from the consulting services customers of $13.5 million, while only $4 million of revenue recognized from noncash consideration in the form of warrants in the nine months ended September 30, 2023. Cost of Revenues Our total cost of revenues decreased by $840,171, or 8.0%, to $9,708,074 for the nine months ended September 30, 2024 from $10,548,245 for the nine months ended September 30, 2023, mainly attributable to (i) a decrease of $975,454 in the costs of GO IPO consulting services in line with the decrease in revenues of GO IPO consulting services by excluding th e amount recognized from noncash consideration, offset by (ii) an increase of $259,917 in customized software development and services as the sales increased. Gross Profit Our total gross profit increased by $9,285,271, or 116.5%, to $17,255,457 for the nine months ended September 30, 2024 from $7,970,186 for the nine months ended September 30, 2023, mainly attributable to an increase in gross profit of $9,143,868 from GO IPO consulting services, as the Company recognized greater revenues from noncash consideration from IPO customers upon their IPO effectiveness with no associated costs in the nine months ended September 30, 2024 than that recognized in the same period in 2023. For the reason discussed above, our overall gross profit margin increased by 21.0% to 64.0% for the nine months ended September 30, 2024 from 43.0% in the nine months ended September 30, 2023. Selling Expenses Our selling expenses decreased by $688,522, or 51.7%, to $642,225 for the nine months ended September 30, 2024 from $1,330,747 in the nine months ended September 30, 2023, primarily attributable to (i) a decrease of $380,087 in stock-based compensation, as the Company granted shares of common stock to employees and service providers of Sigmaways in 2023, and there was no such event in the current period; and (ii) a decrease of $337,882 in advertising expense due to less advertising activities in the current period. As a percentage of revenues, our selling expenses accounted for 2.4% and 7.2% of our total revenues for the nine months ended September 30, 2024 and 2023, respectively. 9 General and Administrative Expenses Our general and administrative expenses decreased by $909,963, or 12.5%, to $6,395,429 for the nine months ended September 30, 2024 from $7,305,392 in the nine months ended September 30, 2023, primarily attributable to (i) a decrease of $566,923 in stock-based compensation, as the Company granted shares of common stock to employees and service providers of Sigmaways in 2023, and there was no such event in the current period; and (ii) a decrease of $314,119 in salaries welfare mainly due to the retirement of certain employees. As a percentage of revenues, our general and administrative expenses were 23.8% and 39.4% of our total revenues for the nine months ended September 30, 2024 and 2023, respectively. Research and Development Expenses Our research and development expenses slightly increased by $18,628, or 6.4%, to $307,931 in the nine months ended September 30, 2024 from $289,303 in the nine months ended September 30, 2023, primarily attributable to (i) an increase of $75,981 in outsourcing expenses relating to the development of new CMS management screen features in the current period; offset by (ii) a decrease of $57,353 in stock-based compensation, as the Company granted shares of common stock to employees and service providers of Sigmaways in 2023, and there was no such event in the current period. As a percentage of revenues, our research and development expenses were 1.1% and 1.6% of our total revenues for the nine months ended September 30, 2024 and 2023, respectively. Other Income (Expenses), Net Our other income (expenses) primarily includes changes in fair value of investments in marketable securities, changes in fair value of investment in warrants, loss on sale of warrants, interest income generated from bank deposits, interest expense for bank loans and bond, other income, and other expenses. Other expenses, net, of $741,827 for the nine months ended September 30, 2023 increased by $1,967,290, or 265.2%, to other expenses, net, of $2,709,117 for the nine months ended September 30, 2024, primarily attributable to a loss of $3,970,628 on sale of warrants, offset by an increase of $192,703 in changes in fair value of investments in marketable securities and an increase of $1,926,265 in changes in fair value of investment in warrants. Income Tax Expense Income tax expense was $72,945 for the nine months ended September 30, 2024, an increase of $14,086, or 23.9%, from income tax expense of $58,859 in the nine months ended September 30, 2023, primarily due to an income before income tax provision in the current period, while we recorded a loss before income tax provision in the nine months ended September 30, 2023. Net Income (Loss) As a result of the foregoing, we reported a net income of $7,127,810 for the nine months ended September 30, 2024, representing a $8,883,752, or 505.9%, increase from a loss of $1,755,942 for the nine months ended September 30, 2023. Net Loss Attributable to Non-controlling Interests We owned 51% equity interest in Sigmaways and its subsidiaries and 51% equity interest of HeartCore Luvina. Accordingly, we recorded net loss attributable to non-controlling interests of $645,546 and $419,211 for the nine months ended September 30, 2024 and 2023, respectively. 10 Net Income (Loss) Attributable to HeartCore Enterprises, Inc. As a result of the foregoing, we reported a net income attributable to HeartCore Enterprises, Inc. of $7,773,356 for the nine months ended September 30, 2024, representing a $9,110,087, or 681.5%, increase from a net loss attributable to HeartCore Enterprises, Inc. of $1,336,731 for the nine months ended September 30, 2023. Liquidity and Capital Resources As of September 30, 2024, we had $1,232,117 in cash and cash equivalents, as compared to $1,012,479 as of December 31, 2023. We also had $2,578,855 in accounts receivable, current as of September 30, 2024. Our accounts receivable primarily include balance due from customers for our on-premise software sold and services provided and accepted by customers, as well as amounts billable to the customers for customized software development and services. The following table sets forth a summary of our cash flows for the periods indicated: For the Nine Months Ended September 30, 2024 2023 Net cash flows used in operating activities $ (3,499,514 ) $ (2,457,661 ) Net cash flows provided by (used in) investing activities 5,317,323 (1,781,810 ) Net cash flows used in financing activities (1,529,441 ) (432,051 ) Effect of exchange rate changes (68,730 ) (306,239 ) Net change in cash and cash equivalents 219,638 (4,977,761 ) Cash and cash equivalents, beginning of the period 1,012,479 7,177,326 Cash and cash equivalents, end of the period $ 1,232,117 $ 2,199,565 Operating Activities Net cash flows used in operating activities was $3,499,514 for the nine months ended September 30, 2024, primarily consisting of the following: ● Net income of $7,127,810 for the nine months ended September 30, 2024. ● Marketable securities and warrants received as noncash consideration in total of $13,541,693 as two of our IPO consulting customers completed the IPO during the current period. ● A gain of $1,631,700 on fair value changes in investment in warrants. ● An increase of $685,531 in accounts receivable due to increased sale of on-premise software in the current period. ● Offset by loss of $3,970,628 recognized on sale of warrants to a third party. ● Offset by depreciation and amortization expenses of $561,659. ● Offset by an increase of $540,008 in other liabilities, mainly because we terminated the consulting service agreement with a GO IPO customer and will refund $500,000 to the customer. Investing Activities Net cash flows provided by investing activities amounted to $5,317,323 for the nine months ended September 30, 2024, primarily attributable to net proceeds from sale of warrants of $5,640,000, offset by payment of $350,000 to purchase long-term investment in SAFE. Financing Activities Net cash flows used in financing activities amounted to $1,529,441 for the nine months ended September 30, 2024, primarily consisting of repayment of $453,048 for short-term and long-term debts, net repayment of $257,295 for factoring arrangement, and dividend distribution of $834,566. 11 Contractual Obligations Lease Commitment The Company has entered into six leases for its office space, one of which was terminated in February 2024, and these leases were classified as operating leases. It has also entered into a lease for office equipment and it was terminated in March 2024, and two leases for vehicles, one of which was terminated in September 2023, and these leases were classified as finance leases. As of September 30, 2024, future minimum lease payments under the non-cancelable lease agreements are as follows: Year Ended December 31, Finance Leases Operating Leases Remaining of 2024 $ 4,545 $ 107,999 2025 18,179 403,889 2026 18,179 329,040 2027 18,179 283,512 2028 12,119 283,512 Thereafter - 942,387 Total lease payments 71,201 2,350,339 Less: imputed interest (1,821 ) (107,797 ) Total lease liabilities 69,380 2,242,542 Less: current portion (17,375 ) (382,594 ) Non-current lease liabilities $ 52,005 $ 1,859,948 Debts The Company’s debts included long-term debts borrowed from banks and financial institutions. As of September 30, 2024, future minimum principal payments for long-term debts are as follows: Principal Year End ed December 31, Payment Remaining of 2024 $ 99,325 2025 434,474 2026 386,063 2027 414,474 2028 187,152 Thereafter 336,584 Total $ 1,858,072 Off-Balance Sheet Arrangements We did not have any off-balance sheet arrangements as of September 30, 2024. Critical Accounting Policies and Estimates Our discussion and analysis of our financial condition and results of operations are based upon our unaudited consolidated financial statements. These financial statements are prepared in accordance with the generally accepted accounting principles in the United States (“U.S. GAAP”), which requires us to make estimates and assumptions that affect the reported amounts of our assets and liabilities and revenues and expenses, to disclose contingent assets and liabilities on the date of the unaudited consolidated financial statements, and to disclose the reported amounts of revenues and expenses incurred during the financial reporting period. We continue to evaluate the estimates and assumptions that we believe to be reasonable under the circumstances. We rely on these evaluations as the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Since the use of estimates is an integral component of the financial reporting process, actual results could differ from those estimates. Some of our accounting policies require higher degrees of judgment than others in their application. We believe critical accounting policies as disclosed herein reflect the more significant judgments and estimates used in preparation of our unaudited consolidated financial statements. 12 Revenue Recognition The Company recognizes revenues under the Financial Accounting Standards Board’s Accounting Standards Codification (“ASC”) Topic 606, “Revenue from Contracts with Customers”. To determine revenue recognition for contracts with customers, the Company performs the following five steps: (i) identify the contract(s) with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance obligation. Revenues amount represents the invoiced value, net of a value-added tax (“Consumption Tax”) and applicable local government levies. The Consumption Tax on sales are calculated at 10% of gross sales in Japan and Vietnam, 5% of gross sales in Canada, 21% of gross sales in Netherlands and nil of gross sales in the United States. The Company currently generates its revenue from the following main sources: Revenues from On-Premise Software Licenses for on-premise software provide the customers with a right to use the software as it exists when made available to the customers. The Company provides on-premise software in the form of both perpetual licenses and term-based licenses which grant the customers with the right for a specified term. Revenues from on-premise licenses are recognized upfront at the point in time when the software is made available to the customers. Licenses for on-premise software are typically sold to the customers with maintenance and support services in a bundle. Revenues under the bundled arrangements are allocated based on the relative standalone selling prices (“SSP”) of on-premise software and maintenance and support service. The SSP for maintenance and support services is estimated based upon observable transactions when those services are sold on a standalone basis. The SSP of on-premise software is typically estimated using the residual approach as the Company is unable to establish the SSP for on-premise licenses based on observable prices given the same products are sold for a broad range of amounts (that is, the selling price is highly variable) and a representative SSP is not discernible from past transactions or other observable evidence. Revenues from Maintenance and Support Services Maintenance and support services provided with software licenses consist of trouble shooting, technical support and the right to receive unspecified software updates when and if available during the subscription. Revenues from maintenance and support services are recognized over time as such services are performed. Revenues for consumption-based services are generally recognized as the services are performed and accepted by the customers. Revenues from Software as a Service (“SaaS”) The Company’s software is available for use as hosted application arrangements under subscription fee agreements without licensing the rights of the software to the customers. Subscription fees from these applications are recognized over time on a ratable basis over the customer agreement term beginning on the date the Company’s solution is made available to the customers. The subscription contracts are generally one year or less in length. Revenues from Software Development and Other Miscellaneous Services The Company provides customers with software development and support services pursuant to their specific requirements, which are primarily composed of consulting, integration, training, custom application, and workflow development. The Company also provides other miscellaneous services, such as 3D space photography. The Company generally recognizes revenues at a point in time when control is transferred to the customers and the Company is entitled to the payment, which is when the promised services are delivered and accepted by the customers. 13 Revenues from Customized Software Development and Services The Company’s customized software development and services revenues primarily include revenues from providing software development solutions and other support services to its customers. The contract pricing is at stated billing rates per hour. These contracts are generally short-term in nature and not longer than one year in duration. For services provided under the contracts that result in the transfer of control over time, the underlying deliverable in the contracts is owned and controlled by the customers and does not create an asset with an alternative use to the Company. The Company recognizes revenues on rate per hour contracts based on the amount billable to the customers, as the Company has the right to invoice the customers in an amount that directly corresponds with the value to the customers of the Company’s performance to date. Revenues from Consulting Services The Company provides public listing related consulting services to customers pursuant to the specific requirements prescribed in the contracts, which primarily include communicating with intermediary parties, preparing required documents related to the initial public offering and supporting the listing process. The consulting service contracts normally include both cash and noncash considerations. Cash consideration is paid in installment payments and is recognized in revenues over the period of the contract by reference to progress toward complete satisfaction of that performance obligation. Noncash consideration is in the form of warrants of the customers and is measured at fair value at contract inception. Noncash consideration that is variable for reasons other than only the form of the consideration is included in the transaction price, but is subject to the constraint on variable consideration. The Company assesses the estimated amount of the variable noncash consideration at contract inception and subsequently, to determine when and to what extent it is probable that a significant reversal in the amount of cumulative revenues recognized will not occur once the uncertainty associated with the variable consideration is subsequently resolved. Only when the significant revenues reversal is concluded probable of not occurring can variable consideration be included in revenues. Based on evaluation of likelihood and magnitude of a reversal in applying the constraint, the variable noncash consideration is recognized in revenues until the underlying uncertainties have been resolved. The Company records reduction to revenues for estimated customer returns and allowances. The Company bases its estimates on historical rates of customer returns and allowances as well as the specific identification of outstanding returns. The actual amount of customer returns and allowances, which is inherently uncertain, may differ from the Company’s estimates. If the Company determines that actual or expected returns or allowances are significantly higher or lower than the reserves it established, it would record a reduction or increase, as appropriate, to revenues in the period in which it makes such a determination. Reserves for customer refunds are included within other current liabilities on the consolidated balance sheets. At a minimum, the Company reviews and refines these estimates on a quarterly basis. The timing of revenue recognition may differ from the timing of invoicing to the customers. The Company has determined that its contracts do not include a significant financing component. The Company records a contract asset, which is included in accounts receivable, current and non-current, in the consolidated balance sheets, when revenues are recognized prior to invoicing. The Company factors certain accounts receivable upon or after the performance obligation is being met. The Company records deferred revenue in the consolidated balance sheets when revenues are recognized subsequent to cash collection for an invoice. Deferred revenue is reported net of related uncollected deferred revenue in the consolidated balance sheets. The amount of revenues recognized during the nine months ended September 30, 2024 and 2023 that were included in the opening deferred revenue balance was approximately $1.8 million and $1.5 million, respectively. ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK Not applicable. ITEM 4. CONTROLS AND PROCEDURES The Company’s Chief Executive Officer and Chief Financial Officer have evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of September 30, 2024. Based upon such evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that, as of September 30, 2024, the Company’s disclosure controls and procedures were not effective, for the same reason as previously disclosed under Item 9A. “Controls and Procedures” in our Annual Report on Form 10-K for our fiscal year ended December 31, 2023, as filed with the Securities and Exchange Commission on April 9, 2024. Changes in Internal Control Over Financial Reporting There were no changes in the Company’s internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Rule 13a-15 or 15d-15 of the Exchange Act that occurred during the quarter ended September 30, 2024 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting. 14 PART II - OTHER INFORMATION ITEM 1. LEGAL PROCEEDINGS From time to time, we are involved in various claims and legal actions arising in the ordinary course of business. To the knowledge of our management, there are no legal proceedings currently pending against us which we believe would have a material effect on our business, financial position or results of operations and, to the best of our knowledge, there are no such legal proceedings contemplated or threatened. ITEM 1A. RISK FACTORS As a smaller reporting company, the Company is not required to disclose material changes to the risk factors that were contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, as updated from time to time. ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS None. ITEM 3. DEFAULTS UPON SENIOR SECURITIES There have been no defaults in any material payments during the covered period. ITEM 4. MINE SAFETY DISCLOSURES Not applicable. ITEM 5. OTHER INFORMATION (a) None. (b) There have been no material changes to the procedures by which security holders may recommend nominees to the Company’s Board of Directors since the Company last provided disclosure in response to the requirements of Item 407(c)(3) of Regulation S-K. (c) During the quarter ended September 30, 2024, no director or officer of the Company adopted or terminated a contract, instruction or written plan for the purchase or sale of securities of the Company intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) and/or a non-Rule 10b5-1 trading arrangement. ITEM 6. EXHIBITS Exhibit Number Description of Document 31.1* Rule 13a-14(a) Certification of Principal Executive Officer. 31.2* Rule 13a-14(a) Certification of Principal Financial Officer. 32.1** Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, of Principal Executive Officer and Principal Financial Officer. 101.INS* Inline XBRL Instance Document 101.SCH* Inline XBRL Taxonomy Extension Schema Document 101.CAL* Inline XBRL Taxonomy Extension Calculation Linkbase 101.DEF* Inline XBRL Taxonomy Extension Definition Linkbase 101.LAB* Inline XBRL Taxonomy Extension Labels Linkbase 101.PRE* Inline XBRL Taxonomy Extension Presentation Linkbase 104* Cover Page Interactive Data File (embedded within the Inline XBRL document) * Filed herewith. ** Furnished herewith. 15 SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, thereto duly authorized. HEARTCORE ENTERPRISES, INC. Dated: November 14, 2024 By: /s/ Sumitaka Yamamoto Sumitaka Yamamoto Chief Executive Officer and President (principal executive officer) Dated: November 14, 2024 By: /s/ Qizhi Gao Qizhi Gao Chief Financial Officer (principal financial officer and principal accounting officer) 16